|
G |
Dot1l |
DOT1 like histone lysine methyltransferase |
treatment |
ISO |
|
RGD |
PMID:23801631 |
RGD:9588291 |
NCBI chrNW_004936588:1,288,447...1,332,489
Ensembl chrNW_004936588:1,288,392...1,330,297
|
|
G |
Rnf20 |
ring finger protein 20 |
disease_progression |
ISO |
|
RGD |
PMID:23412334 |
RGD:9831405 |
NCBI chrNW_004936524:9,690,611...9,715,579
Ensembl chrNW_004936524:9,690,566...9,717,173
|
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
|
ISO |
ClinVar Annotator: match by term: Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified |
ClinVar |
PMID:7585650 PMID:8571952 PMID:9195225 PMID:9238033 PMID:15982307 PMID:16135823 PMID:22234153 PMID:23221806 PMID:23232694 PMID:24728327 PMID:25716912 PMID:25741868 PMID:26884178 PMID:27504877 PMID:28492532 PMID:29607586 PMID:35699229 More...
|
|
NCBI chrNW_004936706:1,816,561...1,829,638
Ensembl chrNW_004936706:1,816,571...1,829,692
|
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:snps, haplotype:multiple (human) |
CTD RGD |
PMID:22674224 |
RGD:8657089 |
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
treatment |
ISO |
DNA:SNP:5'UTR:rs717620(human) DNA:SNPs: :rs717620(human) |
RGD |
PMID:24404132 PMID:25007187 |
RGD:11080959 RGD:11080979 |
NCBI chrNW_004936636:292,631...341,999
Ensembl chrNW_004936636:292,709...340,393
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11984797 PMID:21898527 |
|
NCBI chrNW_004936487:17,690,206...17,819,619
Ensembl chrNW_004936487:17,690,968...17,819,669
|
|
G |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
susceptibility |
ISO |
|
RGD |
PMID:17065136 |
RGD:11100012 |
NCBI chrNW_004936570:1,315,192...1,322,719
|
|
G |
Aicda |
activation induced cytidine deaminase |
treatment |
ISO |
|
RGD |
PMID:19759560 |
RGD:11039451 |
NCBI chrNW_004936870:25,039...34,601
Ensembl chrNW_004936870:25,039...34,601
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19684603 PMID:19684604 |
|
NCBI chrNW_004936614:1,072,263...1,252,573
Ensembl chrNW_004936614:1,072,260...1,252,283
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chrNW_004936580:1,038,420...1,093,319
Ensembl chrNW_004936580:1,036,973...1,082,984
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
severity |
ISO |
mRNA:increased expression:bone marrow (human) |
RGD |
PMID:25982455 |
RGD:11076595 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bcl2l1 |
BCL2 like 1 |
treatment |
ISO |
mRNA:increased expression:blood, mononuclear cell (human) |
RGD |
PMID:12469194 PMID:19020783 |
RGD:11353852 RGD:11353866 |
NCBI chrNW_004936485:18,654,046...18,707,324
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936619:288,377...432,297
Ensembl chrNW_004936619:288,340...432,315
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22010212 |
|
NCBI chrNW_004936726:554,627...596,334
Ensembl chrNW_004936726:554,758...595,922
|
|
G |
Cast |
calpastatin |
|
ISO |
protein:increased expresssion:B cell |
RGD |
PMID:11264179 |
RGD:5509822 |
NCBI chrNW_004936523:6,688,153...6,798,184
Ensembl chrNW_004936523:6,686,519...6,798,321
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
mRNA:increased expression:bone marrow (human) |
RGD |
PMID:22391157 |
RGD:11352824 |
Ensembl chrNW_004936599:973,838...983,316
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
|
RGD |
PMID:9292526 |
RGD:11352271 |
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G |
Cd46 |
CD46 molecule |
|
ISO |
protein:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:16353080 |
RGD:11352810 |
NCBI chrNW_004936557:5,136,784...5,175,543
|
|
G |
Cd79b |
CD79b molecule |
|
ISO |
protein:decreased expression:bone marrow, mononuclear cell (human) |
RGD |
PMID:21487112 |
RGD:11250414 |
NCBI chrNW_004936541:4,534,233...4,537,448
Ensembl chrNW_004936541:4,534,246...4,537,590
|
|
G |
Cd86 |
CD86 molecule |
severity |
ISO |
protein:increased expression:peripheral blood, bone marrow, mononuclear cell (human) |
RGD |
PMID:24283754 |
RGD:11354967 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Cdk6 |
cyclin dependent kinase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24736461 |
|
NCBI chrNW_004936803:1,025,047...1,229,396
Ensembl chrNW_004936803:1,024,779...1,227,516
|
|
G |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoid leukemia |
ClinVar |
PMID:27993330 |
|
NCBI chrNW_004936652:3,576,975...3,582,790
Ensembl chrNW_004936652:3,538,986...3,581,159
|
|
G |
Cebpe |
CCAAT enhancer binding protein epsilon |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19684604 |
|
NCBI chrNW_004936722:1,207,718...1,209,482
Ensembl chrNW_004936722:1,207,743...1,209,482
|
|
G |
Cfb |
complement factor B |
|
ISO |
DNA:missense mutation:p.R32Q b(human) |
RGD |
PMID:6958349 |
RGD:11041155 |
NCBI chrNW_004936727:1,595,872...1,602,274
Ensembl chrNW_004936727:1,595,499...1,602,215
|
|
G |
Crebbp |
CREB binding protein |
disease_progression |
ISO |
DNA:mutations:multiple |
RGD |
PMID:25917266 |
RGD:11060149 |
NCBI chrNW_004936694:552,447...663,237
Ensembl chrNW_004936694:553,753...663,617
|
|
G |
Crlf2 |
cytokine receptor like factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19838194 |
|
NCBI chrNW_004936644:3,866,973...3,872,749
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:9250830 |
RGD:11039038 |
NCBI chrNW_004936490:15,142,526...15,146,375
Ensembl chrNW_004936490:15,142,808...15,144,487
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
severity |
ISO |
|
RGD |
PMID:8562939 |
RGD:734840 |
NCBI chrNW_004936471:34,438,676...34,475,005
Ensembl chrNW_004936471:34,438,676...34,475,052
|
|
G |
Dhfr |
dihydrofolate reductase |
disease_progression |
ISO |
DNA:polymorphisms, haplotype:promoter: DNA:polymorphisms: :-317A>G, 829C>T (human) |
RGD |
PMID:9226157 PMID:12972803 PMID:19861437 PMID:22969948 |
RGD:11039542 RGD:11039543 RGD:11039544 RGD:11039545 |
NCBI chrNW_004936469:67,962...83,116
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
treatment |
ISO |
DNA:mutations:exon, intron:p.R882(human) |
RGD |
PMID:25242092 |
RGD:11041125 |
NCBI chrNW_004936493:6,963,406...7,013,256
Ensembl chrNW_004936493:6,935,386...7,007,610
|
|
G |
Dntt |
DNA nucleotidylexotransferase |
|
ISO |
protein:increased activity:peripheral blood,bone marrow: |
RGD |
PMID:7020399 |
RGD:8694149 |
NCBI chrNW_004936636:3,153,454...3,189,774
Ensembl chrNW_004936636:3,153,569...3,189,774
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
disease_progression no_association |
ISO |
DNA:SNP: :85T>C (human) DNA:splice-site mutation:intron:IVS14+1G>A (human) DNA:SNPs: :2194G>A, 1156G>T (human) |
RGD |
PMID:26846104 |
RGD:11098453 |
NCBI chrNW_004936537:1,660,461...2,439,305
Ensembl chrNW_004936537:1,660,477...2,439,273
|
|
G |
Ehmt1 |
euchromatic histone lysine methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32889036 |
|
NCBI chrNW_004936669:321,580...450,061
Ensembl chrNW_004936669:321,249...423,018
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32889036 |
|
NCBI chrNW_004936727:1,648,451...1,663,294
Ensembl chrNW_004936727:1,648,448...1,663,455
|
|
G |
Eng |
endoglin |
disease_progression |
ISO |
|
RGD |
PMID:17572488 |
RGD:11041565 |
NCBI chrNW_004936487:15,467,165...15,499,180
Ensembl chrNW_004936487:15,467,835...15,477,488
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
no_association susceptibility |
ISO |
DNA:SNPs:exon:rs1051740, rs2234922 (human) DNA:polymorphisms:exon DNA:missense mutation, haplotype:exon:p.Y113H (human) DNA:missense mutation, haplotype:exon:p.H139R (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19593802 PMID:21983886 PMID:22200898 PMID:22930568 |
RGD:11252110 RGD:11252111 RGD:11252113 RGD:11252114 |
NCBI chrNW_004936526:2,589,254...2,652,831
Ensembl chrNW_004936526:2,614,059...2,653,286
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
susceptibility |
ISO |
DNA:SNPs: :8092C>A, 19007G>A (human) DNA:SNPs, haplotypes: :p.R194W, p.R280H, p.R399Q (human) |
RGD |
PMID:16435384 PMID:16723154 |
RGD:11252160 RGD:11340204 |
NCBI chrNW_004936706:1,854,938...1,867,521
Ensembl chrNW_004936706:1,852,359...1,867,745
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
no_association |
ISO |
DNA:haplotype DNA:missense mutations: :p.D312N, p.K751Q (human) |
RGD |
PMID:19101034 PMID:21987080 |
RGD:11252192 RGD:11340201 |
NCBI chrNW_004936706:1,816,561...1,829,638
Ensembl chrNW_004936706:1,816,571...1,829,692
|
|
G |
Erg |
ETS transcription factor ERG |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoid leukemia |
ClinVar |
PMID:27993330 |
|
NCBI chrNW_004936500:4,459,298...4,623,290
Ensembl chrNW_004936500:4,459,275...4,624,432
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoid leukemia |
ClinVar |
PMID:26102509 |
|
NCBI chrNW_004936587:5,328,467...5,457,260
Ensembl chrNW_004936587:5,330,665...5,457,264
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 |
MouseDO |
|
|
NCBI chrNW_004936527:5,024,077...5,069,152
Ensembl chrNW_004936527:5,024,068...5,063,939
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
|
RGD |
PMID:8429686 |
RGD:11340211 |
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
|
|
G |
Fas |
Fas cell surface death receptor |
disease_progression |
ISO |
protein:increased expression:CD34+ bone marrow cell |
RGD |
PMID:9711907 PMID:10500800 |
RGD:11049148 RGD:11049157 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:25317080 |
RGD:11040558 |
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Flt3 |
fms related receptor tyrosine kinase 3 |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoid leukemia |
ClinVar OMIM |
PMID:11290608 PMID:11442493 PMID:14604974 PMID:14670924 PMID:15256420 PMID:16857985 PMID:17606455 PMID:17889720 PMID:19657110 PMID:20733134 PMID:22368270 PMID:22504183 PMID:22504184 PMID:23261068 PMID:23321257 PMID:23430109 PMID:23714533 PMID:23783394 PMID:24046014 PMID:25157968 More...
|
|
NCBI chrNW_004936472:23,169,967...23,239,178
Ensembl chrNW_004936472:23,170,470...23,256,904
|
|
G |
Fpgs |
folylpolyglutamate synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25013492 |
|
NCBI chrNW_004936487:15,453,010...15,466,591
Ensembl chrNW_004936487:15,453,032...15,468,985
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35115686 |
|
NCBI chrNW_004936484:6,780,692...6,800,883
Ensembl chrNW_004936484:6,780,692...6,800,966
|
|
G |
Gfi1b |
growth factor independent 1B transcriptional repressor |
|
ISO |
mRNA:increased expression:blood: |
RGD |
PMID:19360458 |
RGD:11040460 |
NCBI chrNW_004936487:19,414,135...19,417,465
Ensembl chrNW_004936487:19,414,135...19,417,465
|
|
G |
Gnb1 |
G protein subunit beta 1 |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoblastic leukemia | ClinVar Annotator: match by term: Acute lymphoid leukemia | ClinVar Annotator: match by term: Lymphoblastic leukemia |
OMIM ClinVar |
PMID:25485910 PMID:25741868 PMID:27108799 PMID:28492532 PMID:32134617 PMID:32901917 More...
|
|
NCBI chrNW_004936737:1,518,855...1,554,926
Ensembl chrNW_004936737:1,524,325...1,555,102
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
|
ISO |
|
RGD |
PMID:6589021 |
RGD:11051848 |
NCBI chrNW_004936570:1,582,120...1,608,537
Ensembl chrNW_004936570:1,579,372...1,608,788
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
ISO |
|
RGD |
PMID:17317918 PMID:24698347 |
RGD:11352774 RGD:11352812 |
NCBI chrNW_004936529:997,943...999,123
Ensembl chrNW_004936529:998,150...998,987
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
ISO |
|
RGD |
PMID:24191316 |
RGD:11059506 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
disease_progression no_association susceptibility |
ISO |
DNA:haplotype:cds: DNA:polymorphism: :1578 a>G(human) DNA:transition mutation:exon: |
RGD |
PMID:10666194 PMID:15738600 PMID:23979883 |
RGD:10450829 RGD:10755321 RGD:10755417 |
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
H1-2 |
H1.2 linker histone, cluster member |
susceptibility |
ISO |
DNA:SNP, haplotype:enhancer: (rs807212) (human) |
RGD |
PMID:19806355 |
RGD:10755490 |
NCBI chrNW_004936671:1,907,356...1,911,821
Ensembl chrNW_004936671:1,907,321...1,911,851
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17344919 |
|
NCBI chrNW_004936485:18,996,016...19,017,908
Ensembl chrNW_004936485:18,978,412...19,017,908
|
|
G |
Hdac1 |
histone deacetylase 1 |
disease_progression |
ISO |
mRNA:increased expression:bone marrow,blood: |
RGD |
PMID:23948281 |
RGD:9681454 |
NCBI chrNW_004936474:15,320,635...15,351,418
Ensembl chrNW_004936474:15,320,729...15,350,860
|
|
G |
Hdac2 |
histone deacetylase 2 |
disease_progression |
ISO |
mRNA:increased expression:bone marrow,blood: |
RGD |
PMID:23948281 |
RGD:9681454 |
NCBI chrNW_004936679:2,448,676...2,474,641
Ensembl chrNW_004936679:2,448,390...2,474,641
|
|
G |
Hdac4 |
histone deacetylase 4 |
treatment |
ISO |
|
RGD |
PMID:23948281 |
RGD:9681454 |
NCBI chrNW_004936745:1,730,743...1,942,071
Ensembl chrNW_004936745:1,730,694...1,942,074
|
|
G |
Hfe |
homeostatic iron regulator |
no_association |
ISO |
DNA:missense mutation: :p.H63D (human) DNA:missense mutation:cds:p.H63D (human) DNA:missense mutation:cds:p.C282Y (human) |
RGD |
PMID:10627122 PMID:17107905 |
RGD:10755557 RGD:10755558 |
NCBI chrNW_004936671:1,940,079...1,947,574
Ensembl chrNW_004936671:1,940,101...1,947,580
|
|
G |
Hk1 |
hexokinase 1 |
|
ISO |
protein:decreased activity:platelet |
RGD |
PMID:21921332 |
RGD:11353881 |
NCBI chrNW_004936521:9,067,062...9,139,112
Ensembl chrNW_004936521:9,066,999...9,159,793
|
|
G |
Hlf |
HLF transcription factor, PAR bZIP family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26214592 |
|
NCBI chrNW_004936490:7,273,051...7,324,681
Ensembl chrNW_004936490:7,273,112...7,324,687
|
|
G |
Hoxd4 |
homeobox D4 |
|
ISO |
ClinVar Annotator: match by term: Leukemia, acute lymphoblastic, susceptibility to |
ClinVar |
PMID:15776434 |
|
NCBI chrNW_004936509:5,637,600...5,640,335
Ensembl chrNW_004936509:5,637,600...5,640,917
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
|
|
G |
Ifng |
interferon gamma |
susceptibility |
ISO |
DNA:SNP: :rs2069727(human) |
RGD |
PMID:21067287 |
RGD:10755691 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
|
ISO |
ClinVar Annotator: match by term: Acute lymphocytic leukemia | ClinVar Annotator: match by term: Acute lymphoid leukemia | ClinVar Annotator: match by term: Leukemia, acute lymphocytic, susceptibility to, 2 |
ClinVar |
PMID:25741868 PMID:27993330 PMID:28492532 |
|
NCBI chrNW_004936686:1,459,582...1,556,478
Ensembl chrNW_004936686:1,462,145...1,556,451
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chrNW_004936586:3,522,614...3,676,070
Ensembl chrNW_004936586:3,525,933...3,674,061
|
|
G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chrNW_004936490:14,939,693...15,025,728
Ensembl chrNW_004936490:14,939,776...15,025,728
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
protein:decreased expression:blood |
RGD |
PMID:15860861 PMID:21653647 |
RGD:11049158 RGD:11049169 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
DNA:SNP:intron:rs12203592 (human) |
RGD |
PMID:19897031 |
RGD:11526162 |
NCBI chrNW_004936633:1,565,293...1,580,859
Ensembl chrNW_004936633:1,564,637...1,580,859
|
|
G |
Itpa |
inosine triphosphatase |
treatment no_association |
ISO |
DNA:SNPs:exon:94C>A, 138G>A (human) DNA:SNP:intron |
RGD |
PMID:22009189 |
RGD:10766474 |
NCBI chrNW_004936485:15,499,688...15,511,992
Ensembl chrNW_004936485:15,497,822...15,511,992
|
|
G |
Kdm2b |
lysine demethylase 2B |
|
ISO |
mRNA:increased expression:bone marrow (human) |
RGD |
PMID:21310926 |
RGD:9588255 |
NCBI chrNW_004936558:2,771,420...2,897,694
Ensembl chrNW_004936558:2,771,420...2,897,292
|
|
G |
Kdm3b |
lysine demethylase 3B |
|
ISO |
protein:increased expression:bone marrow, mononuclear cell (human) |
RGD |
PMID:22615488 |
RGD:9586728 |
NCBI chrNW_004936531:7,517,810...7,600,319
Ensembl chrNW_004936531:7,516,125...7,600,347
|
|
G |
Kdm6a |
lysine demethylase 6A |
severity |
ISO |
DNA:mutations:cds:multiple (human) |
RGD |
PMID:22377896 |
RGD:9684944 |
NCBI chrNW_004936502:10,980,303...11,196,711
Ensembl chrNW_004936502:10,980,118...11,196,163
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 |
CTD MouseDO |
PMID:24736461 PMID:25730765 |
|
NCBI chrNW_004936542:3,480,071...3,566,823
Ensembl chrNW_004936542:3,391,774...3,562,147
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
disease_progression |
ISO |
|
RGD |
PMID:17910045 PMID:25917266 |
RGD:11060148 RGD:11060149 |
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G |
Lmo2 |
LIM domain only 2 |
|
ISO |
OMIM:247640 | OMIM:613065 |
MouseDO |
|
|
NCBI chrNW_004936533:4,107,073...4,117,121
Ensembl chrNW_004936533:4,107,067...4,117,222
|
|
G |
LOC101961588 |
cytochrome P450 2D17 |
susceptibility |
ISO |
DNA:SNP,deletion:splice junction,exon:1934G>A(human) DNA:polymorphisms: : |
RGD |
PMID:11037802 PMID:19593802 |
RGD:11252111 RGD:11352820 |
NCBI chrNW_004936718:153,340...157,966
|
|
G |
LOC101967032 |
cytochrome b-245 light chain |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell: |
RGD |
PMID:19222940 |
RGD:11040545 |
NCBI chrNW_004936641:1,036,967...1,044,954
Ensembl chrNW_004936641:1,036,967...1,044,991
|
|
G |
LOC101969021 |
somatotropin |
treatment |
ISO |
|
RGD |
PMID:2494952 |
RGD:11352727 |
NCBI chrNW_004936541:4,524,397...4,528,234
|
|
G |
LOC101969148 |
cytochrome P450 1A1 |
susceptibility no_association |
ISO |
DNA:polymorphism:cds:2452C>A(p.T461N)(human) DNA:polymorphism:3"UTR:rs4646903(human) DNA:polymorphism:3'UTR:3801T>C(human) |
RGD |
PMID:16676594 PMID:22964275 PMID:23725389 |
RGD:11352714 RGD:11352725 RGD:11352728 |
NCBI chrNW_004936471:33,682,730...33,688,332
Ensembl chrNW_004936471:33,682,730...33,688,332
|
|
G |
LOC101969421 |
cytochrome P450 1A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chrNW_004936471:33,704,616...33,709,455
Ensembl chrNW_004936471:33,703,792...33,709,484
|
|
G |
LOC101970101 |
cytochrome P450 1B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chrNW_004936663:345,021...355,188
Ensembl chrNW_004936663:348,368...355,191
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11774269 |
|
NCBI chrNW_004936486:19,691,822...19,702,684
Ensembl chrNW_004936486:19,691,822...19,702,102
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
susceptibility |
ISO |
DNA:polymorphisms:cds:p.E148Q,M680I(human) |
RGD |
PMID:22942567 |
RGD:11531121 |
NCBI chrNW_004936694:970,706...980,605
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
disease_progression treatment |
ISO |
DNA:missense mutation:cds:677C>T (p.A222V) (rs1801133) (human) DNA:missense mutation:cds:677C>T (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16706930 PMID:19923983 PMID:21644011 |
RGD:10449398 RGD:10449407 |
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
susceptibility no_association disease_progression |
ISO |
DNA:polymorphism: :2756A>G(human) DNA:SNP::rs10925235(human) DNA:polymorphism: :66A>G(human) |
RGD |
PMID:15159311 PMID:21618417 PMID:22453148 PMID:26605150 |
RGD:11531136 RGD:11531137 RGD:11531140 RGD:11531141 |
NCBI chrNW_004936484:16,087,924...16,180,089
Ensembl chrNW_004936484:16,087,923...16,180,148
|
|
G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
susceptibility |
ISO |
DNA:SNP: :rs3776455(human) DNA:haplotype:cds: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17136115 PMID:23940529 |
RGD:11531133 RGD:11531135 |
NCBI chrNW_004936643:379,790...410,034
Ensembl chrNW_004936643:380,968...409,464
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
disease_progression |
ISO |
|
RGD |
PMID:25784651 |
RGD:11532748 |
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
|
|
G |
Nbn |
nibrin |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoblastic leukemia | ClinVar Annotator: match by term: Acute lymphocytic leukemia | ClinVar Annotator: match by term: Acute lymphoid leukemia | ClinVar Annotator: match by term: Lymphoblastic leukemia |
OMIM ClinVar |
PMID:9590180 PMID:11325820 PMID:12353271 PMID:14559852 PMID:15338273 PMID:16415040 PMID:16474176 PMID:16770759 PMID:16810201 PMID:17001621 PMID:17496786 PMID:17695489 PMID:17894553 PMID:17899368 PMID:18023021 PMID:18049891 PMID:18280732 PMID:18606567 PMID:18612309 PMID:18638378 PMID:19393249 PMID:19452044 PMID:19523210 PMID:19584272 PMID:19804756 PMID:19813148 PMID:19908051 PMID:20805886 PMID:21212067 PMID:21302341 PMID:21698754 PMID:22131123 PMID:22373003 PMID:22491912 PMID:22841127 PMID:22864661 PMID:22995991 PMID:23317186 PMID:23555315 PMID:24033266 PMID:24093751 PMID:24113799 PMID:24396275 PMID:24549055 PMID:24728327 PMID:24830725 PMID:24894818 PMID:25117502 PMID:25186627 PMID:25318351 PMID:25503501 PMID:25619955 PMID:25712764 PMID:25741868 PMID:25980754 PMID:26083025 PMID:26315354 PMID:26467025 PMID:26564480 PMID:26722329 PMID:26787654 PMID:26898890 PMID:27153395 PMID:27616075 PMID:27621404 PMID:27978560 PMID:28076423 PMID:28135145 PMID:28261280 PMID:28376765 PMID:28492532 PMID:28528518 PMID:28591191 PMID:28726808 PMID:28888541 PMID:29335925 PMID:29371908 PMID:29522266 PMID:29596542 PMID:29615459 PMID:29659569 PMID:29678143 PMID:29785153 PMID:30256826 PMID:30287823 PMID:30306255 PMID:30441849 PMID:30590007 PMID:30651582 PMID:30982232 PMID:31159747 PMID:31206626 PMID:31415627 PMID:31666926 PMID:31780696 PMID:31874108 PMID:32068069 PMID:32427313 PMID:32566746 PMID:32668560 PMID:32832836 PMID:32936981 PMID:32980694 PMID:33309985 PMID:33471991 PMID:33800431 PMID:34072463 PMID:34284872 PMID:35245693 PMID:35264596 PMID:36346689 More...
|
|
NCBI chrNW_004936544:3,773,828...3,812,673
Ensembl chrNW_004936544:3,775,220...3,808,837
|
|
G |
Nos3 |
nitric oxide synthase 3 |
disease_progression susceptibility |
ISO |
DNA:polymorphism, haplotype:cds,intron:P.E298D,-786T>C(human) DNA:SNP: :rs3918186(human) |
RGD |
PMID:20510681 PMID:23922896 |
RGD:11533639 RGD:11533646 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
OMIM:247640 | OMIM:613065 |
MouseDO |
|
|
NCBI chrNW_004936596:5,265,984...5,301,430
Ensembl chrNW_004936596:5,265,999...5,300,429
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
|
ISO |
DNA:missense mutations: :p.R139W (465C>T), p.P187S (609C>T) (human) DNA:mutation: :609C>T (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11774269 PMID:17332311 PMID:18444911 |
RGD:10769347 RGD:10769359 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
disease_progression |
ISO |
DNA:missense mutation:cds: |
RGD |
PMID:25204082 |
RGD:11535045 |
NCBI chrNW_004936627:73,413...82,590
Ensembl chrNW_004936627:73,413...82,590
|
|
G |
Nsd2 |
nuclear receptor binding SET domain protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24076604 |
|
NCBI chrNW_004936477:21,460,442...21,531,563
Ensembl chrNW_004936477:21,460,478...21,534,909
|
|
G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23377183 |
|
NCBI chrNW_004936600:2,828,277...2,892,795
|
|
G |
Nup214 |
nucleoporin 214 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chrNW_004936487:17,981,402...18,067,828
Ensembl chrNW_004936487:17,981,304...18,067,854
|
|
G |
P2ry8 |
P2Y receptor family member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19838194 |
|
NCBI chrNW_004936644:3,768,646...3,770,610
Ensembl chrNW_004936644:3,768,463...3,770,500
|
|
G |
Pag1 |
phosphoprotein membrane anchor with glycosphingolipid microdomains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chrNW_004936656:3,010,603...3,152,674
Ensembl chrNW_004936656:3,129,084...3,143,449
|
|
G |
Pax5 |
paired box 5 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Acute lymphoid leukemia | ClinVar Annotator: match by term: Leukemia, acute lymphoblastic, susceptibility to, 3 |
OMIM ClinVar |
PMID:24013638 PMID:24728327 PMID:25741868 PMID:27993330 PMID:28492532 PMID:30643249 PMID:35094443 More...
|
|
NCBI chrNW_004936524:4,700,815...4,887,035
Ensembl chrNW_004936524:4,700,841...4,887,106
|
|
G |
Pon1 |
paraoxonase 1 |
susceptibility |
ISO |
DNA:missense mutations:cds:p.L55M (rs854560), p.Q192R (rs662) (human) |
RGD |
PMID:22976839 |
RGD:11552580 |
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
|
|
G |
Prame |
PRAME nuclear receptor transcriptional regulator |
severity |
ISO |
mRNA:increased expression:blood (human) |
RGD |
PMID:27275197 |
RGD:11535025 |
NCBI chrNW_004936619:1,748,337...1,751,748
|
|
G |
Prdm14 |
PR/SET domain 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19043588 |
|
NCBI chrNW_004936496:14,789,443...14,820,967
Ensembl chrNW_004936496:14,806,928...14,820,967
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 |
MouseDO |
|
|
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chrNW_004936565:1,596,227...1,746,706
Ensembl chrNW_004936565:1,597,593...1,746,846
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17255265 |
|
NCBI chrNW_004936778:823,376...846,843
Ensembl chrNW_004936778:829,550...848,833
|
|
G |
Snrpe |
small nuclear ribonucleoprotein polypeptide E |
severity |
ISO |
mRNA:decreased expression:bone marrow, blood, mononuclear cell (human) |
RGD |
PMID:23915977 |
RGD:10768836 |
NCBI chrNW_004936567:849,300...855,214
Ensembl chrNW_004936567:849,397...855,187
|
|
G |
Tal1 |
TAL bHLH transcription factor 1, erythroid differentiation factor |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936474:28,049,326...28,061,495
Ensembl chrNW_004936474:28,047,808...28,056,065
|
|
G |
Tcf3 |
transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26214592 |
|
NCBI chrNW_004936588:884,817...913,052
Ensembl chrNW_004936588:884,789...912,753
|
|
G |
Tcn2 |
transcobalamin 2 |
|
ISO |
protein:altered activity:plasma: |
RGD |
PMID:8754152 |
RGD:11059889 |
NCBI chrNW_004936904:97,535...113,886
Ensembl chrNW_004936904:95,542...113,985
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
DNA:SNPs:promoter, introns:g.1296486C>T, g.12866516A>C, g.1279790G>A (rs2735940, rs2736100, rs10069690) (human) |
RGD |
PMID:15621763 PMID:23066086 |
RGD:11038654 RGD:11038667 |
NCBI chrNW_004936815:468,987...492,666
Ensembl chrNW_004936815:469,020...491,697
|
|
G |
Tm9sf2 |
transmembrane 9 superfamily member 2 |
|
ISO |
mRNA:increased expression:bone marrow, mononuclear cells (human) |
RGD |
PMID:12730115 |
RGD:2317244 |
NCBI chrNW_004936472:10,946,263...11,006,311
Ensembl chrNW_004936472:10,945,906...11,006,324
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Tpmt |
thiopurine S-methyltransferase |
treatment no_association |
ISO |
DNA:SNPs:exon:374C>T, 719A>G (rs2842934, rs1142345) (human) DNA:SNPs: :multiple DNA:SNPs:introns:12356C>T, 16638C>T, 26354G>T (rs4449636, rs2518463, rs2842949) (human) DNA:SNPs:multiple |
RGD |
PMID:17164697 PMID:22009189 PMID:24499706 |
RGD:10766474 RGD:11038720 RGD:11038723 |
NCBI chrNW_004936552:3,899,445...3,917,774
Ensembl chrNW_004936552:3,897,375...3,917,772
|
|
G |
Ttc12 |
tetratricopeptide repeat domain 12 |
|
ISO |
DNA:hypermethylation:5'end:CpG dinucleotide |
RGD |
PMID:17657212 |
RGD:405866376 |
NCBI chrNW_004936612:1,194,899...1,241,624
Ensembl chrNW_004936612:1,194,662...1,241,624
|
|
G |
Tyms |
thymidylate synthetase |
treatment |
ISO |
DNA:repeats: : rs347430033(human) |
RGD |
PMID:25007187 |
RGD:11080979 |
NCBI chrNW_004936550:33,797...42,233
Ensembl chrNW_004936550:34,048...41,840
|
|
G |
Vpreb1 |
V-set pre-B cell surrogate light chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26214592 |
|
NCBI chrNW_004936619:1,700,203...1,700,746
Ensembl chrNW_004936619:1,700,203...1,700,746
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
no_association susceptibility |
ISO |
DNA:missense mutation: :p.R399Q (human) DNA:missense mutation: :p.R194W (human) DNA:missense mutation, haplotype: :p.R399Q (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19101034 PMID:21983886 |
RGD:11252110 RGD:11252192 |
NCBI chrNW_004936706:752,571...783,746
Ensembl chrNW_004936706:751,108...783,777
|
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:10988075 PMID:11423618 PMID:11853795 PMID:11861307 PMID:11964322 PMID:12130516 PMID:12399961 PMID:12623848 PMID:14559829 PMID:14745431 PMID:15194504 PMID:15256422 PMID:15381060 PMID:18615627 PMID:19466505 PMID:19652056 PMID:20367437 PMID:20512393 PMID:20537386 PMID:20697894 PMID:20963643 PMID:21505103 PMID:21562040 PMID:21762985 PMID:21872826 PMID:21895409 PMID:22306673 PMID:22772060 PMID:22870928 PMID:23355941 PMID:23540562 PMID:23676790 PMID:24236021 PMID:24456693 PMID:25157968 PMID:25686603 PMID:25741868 PMID:36063163 More...
|
|
NCBI chrNW_004936487:17,690,206...17,819,619
Ensembl chrNW_004936487:17,690,968...17,819,669
|
|
G |
Crlf2 |
cytokine receptor like factor 2 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:19907440 PMID:19965641 PMID:20018760 PMID:22368272 |
|
NCBI chrNW_004936644:3,866,973...3,872,749
|
|
G |
Fgfr1 |
fibroblast growth factor receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156 |
|
NCBI chrNW_004936710:1,760,365...1,815,269
Ensembl chrNW_004936710:1,760,089...1,815,508
|
|
G |
Il7r |
interleukin 7 receptor |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:22897847 PMID:22955920 |
|
NCBI chrNW_004936518:5,815,820...5,842,571
|
|
G |
Insl6 |
insulin like 6 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:18805579 PMID:19470474 PMID:20585391 PMID:22368270 PMID:22955920 |
|
NCBI chrNW_004936503:67,933...78,496
|
|
G |
Jak1 |
Janus kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:16239216 PMID:19139102 PMID:19470474 PMID:19838194 PMID:20167706 PMID:21436584 PMID:21680795 PMID:22955920 PMID:25352124 PMID:28111307 More...
|
|
NCBI chrNW_004936692:2,298,149...2,354,084
Ensembl chrNW_004936692:2,299,504...2,354,132
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:18805579 PMID:19470474 PMID:20585391 PMID:22368270 PMID:22955920 |
|
NCBI chrNW_004936503:111,722...243,627
Ensembl chrNW_004936503:110,963...241,867
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
ClinVar Annotator: match by term: LYMPHOMATOUS ALL |
ClinVar |
PMID:10982185 PMID:16843266 PMID:18270328 PMID:20132407 PMID:20372971 PMID:21599579 PMID:21821710 PMID:24728327 PMID:25157968 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936596:3,212,593...3,224,426
Ensembl chrNW_004936596:3,212,593...3,224,048
|
|
|
G |
Aqp1 |
aquaporin 1 (Colton blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936478:7,146,997...7,160,369
Ensembl chrNW_004936478:7,147,027...7,160,401
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936474:11,148,857...11,197,312
|
|
G |
Arid2 |
AT-rich interaction domain 2 |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
|
|
NCBI chrNW_004936512:4,020,303...4,199,390
Ensembl chrNW_004936512:4,020,966...4,196,459
|
|
G |
Arid4b |
AT-rich interaction domain 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936484:17,116,304...17,257,640
Ensembl chrNW_004936484:17,116,229...17,258,277
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936614:1,072,263...1,252,573
Ensembl chrNW_004936614:1,072,260...1,252,283
|
|
G |
Aspm |
assembly factor for spindle microtubules |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936567:6,653,382...6,701,856
Ensembl chrNW_004936567:6,653,728...6,701,752
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936551:359,134...534,672
Ensembl chrNW_004936551:359,362...532,211
|
|
G |
Atr |
ATR serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:32001675 |
RGD:150340693 |
NCBI chrNW_004936540:4,074,543...4,178,859
Ensembl chrNW_004936540:4,074,570...4,178,898
|
|
G |
Atrx |
ATRX chromatin remodeler |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936683:2,496,307...2,718,539
Ensembl chrNW_004936683:2,495,959...2,718,620
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma | ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
PMID:21642991 PMID:24894717 PMID:26166446 PMID:26452128 PMID:28492532 |
|
NCBI chrNW_004936473:3,239,009...3,247,806
Ensembl chrNW_004936473:3,239,010...3,247,806
|
|
G |
Bcl11a |
BCL11 transcription factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936491:6,021,340...6,118,103
Ensembl chrNW_004936491:6,021,343...6,118,568
|
|
G |
Bcor |
BCL6 corepressor |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
|
|
NCBI chrNW_004936502:6,764,043...6,812,194
Ensembl chrNW_004936502:6,764,907...6,792,916
|
|
G |
Bcorl1 |
BCL6 corepressor like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936479:1,539,676...1,605,647
Ensembl chrNW_004936479:1,538,051...1,606,344
|
|
G |
Brca1 |
BRCA1 DNA repair associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936490:17,735,444...17,801,456
|
|
G |
Brd1 |
bromodomain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936629:909,716...958,620
Ensembl chrNW_004936629:909,680...958,896
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
Ensembl chrNW_004936599:973,838...983,316
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17520682 |
|
NCBI chrNW_004936475:18,990,529...19,065,954
Ensembl chrNW_004936475:18,990,474...19,067,203
|
|
G |
Cmtr2 |
cap methyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936475:22,434,009...22,441,350
Ensembl chrNW_004936475:22,434,180...22,440,846
|
|
G |
Cntn6 |
contactin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936577:1,108,502...1,393,706
Ensembl chrNW_004936577:1,167,211...1,393,521
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:25741868 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
|
|
NCBI chrNW_004936694:552,447...663,237
Ensembl chrNW_004936694:553,753...663,617
|
|
G |
Dapk1 |
death associated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936680:2,842,930...3,020,757
Ensembl chrNW_004936680:2,842,547...3,021,058
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936557:1,347,991...1,389,836
Ensembl chrNW_004936557:1,347,991...1,389,836
|
|
G |
Dtx4 |
deltex E3 ubiquitin ligase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936581:3,433,760...3,467,863
Ensembl chrNW_004936581:3,437,489...3,467,869
|
|
G |
Efhd1 |
EF-hand domain family member D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936525:4,445,779...4,484,674
Ensembl chrNW_004936525:4,445,773...4,484,680
|
|
G |
En1 |
engrailed homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936469:51,439,944...51,451,194
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936492:696,982...778,132
Ensembl chrNW_004936492:696,960...778,138
|
|
G |
Erbin |
erbb2 interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936480:3,155,934...3,293,224
Ensembl chrNW_004936480:3,154,690...3,293,230
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936512:10,556,269...10,576,582
Ensembl chrNW_004936512:10,556,672...10,576,588
|
|
G |
Fanca |
FA complementation group A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936641:281,119...319,796
Ensembl chrNW_004936641:281,073...324,053
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936554:2,872,729...2,996,821
Ensembl chrNW_004936554:2,872,713...2,996,823
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:26619011 |
|
NCBI chrNW_004936689:2,261,163...2,449,951
Ensembl chrNW_004936689:2,259,477...2,344,764
|
|
G |
Fgf16 |
fibroblast growth factor 16 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936683:2,454,067...2,463,653
Ensembl chrNW_004936683:2,454,067...2,463,635
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
PMID:26619011 |
|
NCBI chrNW_004936486:10,506,680...10,606,272
Ensembl chrNW_004936486:10,507,097...10,602,019
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936597:1,388,394...1,397,731
Ensembl chrNW_004936597:1,385,624...1,397,758
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936564:4,788,036...4,907,600
Ensembl chrNW_004936564:4,787,992...4,903,837
|
|
G |
Foxp2 |
forkhead box P2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936589:4,120,162...4,661,258
Ensembl chrNW_004936589:4,123,182...4,382,005
|
|
G |
Gas2 |
growth arrest specific 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936654:3,326,557...3,448,930
Ensembl chrNW_004936654:3,326,511...3,448,872
|
|
G |
Gas6 |
growth arrest specific 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936472:27,116...57,158
Ensembl chrNW_004936472:32,123...54,028
|
|
G |
Gins2 |
GINS complex subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936641:2,757,150...2,775,904
Ensembl chrNW_004936641:2,757,150...2,776,681
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936576:2,353,874...2,411,747
Ensembl chrNW_004936576:2,353,761...2,411,425
|
|
G |
Homer3 |
homer scaffold protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936596:2,406,427...2,413,651
Ensembl chrNW_004936596:2,406,326...2,413,604
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19371735 PMID:19382114 PMID:19669404 PMID:20301680 PMID:20660566 PMID:20979192 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22926243 PMID:23093928 PMID:23429430 PMID:23751039 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25157968 PMID:25741868 PMID:25914166 PMID:26467025 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31222966 PMID:31394527 PMID:31775759 PMID:33372952 PMID:34008892 More...
|
|
NCBI chrNW_004936888:375,372...378,125
Ensembl chrNW_004936888:375,377...377,958
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 PMID:36201590 More...
|
|
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
|
|
G |
Igfbp2 |
insulin like growth factor binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936586:671,760...696,783
Ensembl chrNW_004936586:672,091...696,692
|
|
G |
Il17rd |
interleukin 17 receptor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936473:7,447,292...7,507,819
Ensembl chrNW_004936473:7,447,292...7,507,830
|
|
G |
Insrr |
insulin receptor related receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936580:5,982,259...5,999,994
Ensembl chrNW_004936580:5,983,006...5,999,994
|
|
G |
Irx4 |
iroquois homeobox 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936815:90,707...94,138
Ensembl chrNW_004936815:90,942...94,147
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936596:2,815,782...2,819,100
Ensembl chrNW_004936596:2,815,821...2,819,020
|
|
G |
Itgb4 |
integrin subunit beta 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936594:912,302...944,819
Ensembl chrNW_004936594:912,291...946,012
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936485:8,857,688...8,894,270
Ensembl chrNW_004936485:8,857,669...8,895,315
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:14615376 PMID:28492532 PMID:33040328 |
|
NCBI chrNW_004936596:3,212,593...3,224,426
Ensembl chrNW_004936596:3,212,593...3,224,048
|
|
G |
Jmjd1c |
jumonji domain containing 1C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936753:1,413,935...1,645,974
Ensembl chrNW_004936753:1,414,240...1,645,161
|
|
G |
Kansl1 |
KAT8 regulatory NSL complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936541:2,480,097...2,677,693
Ensembl chrNW_004936541:2,480,849...2,675,991
|
|
G |
Kat6a |
lysine acetyltransferase 6A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936785:602,754...704,504
Ensembl chrNW_004936785:603,478...701,791
|
|
G |
Kdm6a |
lysine demethylase 6A |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism DNA:mutations:multiple: (human) DNA:splice-site mutation, missense mutations:splice junction, CDS:multiple: (human) |
CTD RGD |
PMID:23685749 PMID:31483290 |
RGD:150429732 RGD:150429736 |
NCBI chrNW_004936502:10,980,303...11,196,711
Ensembl chrNW_004936502:10,980,118...11,196,163
|
|
G |
Kdm6b |
lysine demethylase 6B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936595:1,077,318...1,099,082
Ensembl chrNW_004936595:1,089,544...1,097,595
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23685749 PMID:31483290 |
RGD:150429736 |
NCBI chrNW_004936527:7,310,885...7,508,032
Ensembl chrNW_004936527:7,312,721...7,506,365
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:6695174 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16618717 PMID:17384584 PMID:17704260 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:20921462 PMID:20921465 PMID:21228335 PMID:21975775 PMID:22722830 PMID:23182985 PMID:23406027 PMID:25157968 PMID:26242988 PMID:28492532 More...
|
|
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G |
Krt15 |
keratin 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936490:16,431,604...16,436,139
Ensembl chrNW_004936490:16,431,558...16,526,000
|
|
G |
Krt5 |
keratin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936512:9,923,593...9,929,517
Ensembl chrNW_004936512:9,922,523...9,929,517
|
|
G |
LOC101962705 |
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936637:985,706...1,154,670
Ensembl chrNW_004936637:560,298...1,151,850
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19371735 PMID:19382114 PMID:19669404 PMID:20301680 PMID:20660566 PMID:20979192 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22926243 PMID:23093928 PMID:23429430 PMID:23751039 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25157968 PMID:25741868 PMID:25914166 PMID:26467025 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31222966 PMID:31394527 PMID:31775759 PMID:33372952 PMID:34008892 More...
|
|
NCBI chrNW_004936888:379,622...397,647
Ensembl chrNW_004936888:382,062...402,083
|
|
G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936479:21,373,917...22,062,498
Ensembl chrNW_004936479:21,373,746...21,920,214
|
|
G |
Maml3 |
mastermind like transcriptional coactivator 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936535:7,537,420...7,991,983
Ensembl chrNW_004936535:7,599,660...7,989,952
|
|
G |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936588:2,338,127...2,377,090
Ensembl chrNW_004936588:2,336,858...2,377,090
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936679:2,373,104...2,379,230
|
|
G |
Mark2 |
microtubule affinity regulating kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936599:5,226,603...5,287,677
Ensembl chrNW_004936599:5,226,496...5,287,683
|
|
G |
Mecom |
MDS1 and EVI1 complex locus |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
|
|
NCBI chrNW_004936593:2,742,236...3,282,596
Ensembl chrNW_004936593:3,106,202...3,282,596
|
|
G |
Mga |
MAX dimerization protein MGA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936471:4,946,770...5,073,925
Ensembl chrNW_004936471:4,946,124...5,073,849
|
|
G |
Mier2 |
MIER family member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936588:25,272...46,226
Ensembl chrNW_004936588:25,253...46,246
|
|
G |
Mlc1 |
modulator of VRAC current 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936629:696,592...719,363
Ensembl chrNW_004936629:696,451...719,416
|
|
G |
Morf4l1 |
mortality factor 4 like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936471:37,073,920...37,097,216
Ensembl chrNW_004936471:37,073,895...37,097,235
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 PMID:26829750 |
|
NCBI chrNW_004936560:2,797,943...2,828,813
Ensembl chrNW_004936560:2,796,697...2,829,650
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936496:7,395,541...7,436,295
Ensembl chrNW_004936496:7,395,533...7,436,358
|
|
G |
Mycbp |
MYC binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936474:20,837,757...20,871,444
Ensembl chrNW_004936474:20,856,732...20,866,184
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936493:14,618,176...14,624,201
Ensembl chrNW_004936493:14,618,060...14,624,315
|
|
G |
Neto2 |
neuropilin and tolloid like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936475:450,382...508,357
Ensembl chrNW_004936475:450,382...508,357
|
|
G |
Nfib |
nuclear factor I B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936539:7,763,036...8,185,001
Ensembl chrNW_004936539:7,769,413...7,985,316
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
|
|
NCBI chrNW_004936669:1,292,016...1,334,061
Ensembl chrNW_004936669:1,292,088...1,332,428
|
|
G |
Nsd1 |
nuclear receptor binding SET domain protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936597:1,426,318...1,577,193
Ensembl chrNW_004936597:1,425,974...1,572,715
|
|
G |
Ntrk3 |
neurotrophic receptor tyrosine kinase 3 |
treatment |
ISO |
|
RGD |
PMID:23027130 |
RGD:150519921 |
NCBI chrNW_004936483:13,912,904...14,291,881
Ensembl chrNW_004936483:13,909,109...14,291,887
|
|
G |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936721:783,973...787,712
Ensembl chrNW_004936721:782,032...787,952
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936867:426,648...439,512
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:15930273 PMID:17376864 PMID:18074223 PMID:19366826 PMID:22120714 PMID:22658544 PMID:22949682 PMID:23946963 PMID:24033266 PMID:24782230 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27631024 PMID:28151489 PMID:28492532 PMID:29446767 PMID:34008892 More...
|
|
NCBI chrNW_004936566:3,924,013...3,951,052
Ensembl chrNW_004936566:3,923,934...3,951,073
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936590:4,722,914...4,887,615
Ensembl chrNW_004936590:4,722,873...4,890,156
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Pygb |
glycogen phosphorylase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936620:533,574...575,893
Ensembl chrNW_004936620:532,634...575,916
|
|
G |
Rbfox2 |
RNA binding fox-1 homolog 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936492:4,624,013...4,826,715
Ensembl chrNW_004936492:4,645,167...4,821,291
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936538:7,885,816...7,898,308
Ensembl chrNW_004936538:7,885,475...7,899,113
|
|
G |
Setd2 |
SET domain containing 2, histone lysine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936596:795,940...898,823
Ensembl chrNW_004936596:796,601...883,373
|
|
G |
Sf3b1 |
splicing factor 3b subunit 1 |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
PMID:25741868 PMID:26619011 |
|
NCBI chrNW_004936506:1,749,591...1,790,860
Ensembl chrNW_004936506:1,749,563...1,791,739
|
|
G |
Slc24a3 |
solute carrier family 24 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936485:637,715...1,085,860
Ensembl chrNW_004936485:639,532...1,085,830
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
disease_progression |
ISO |
|
RGD |
PMID:23516127 |
RGD:151361211 |
NCBI chrNW_004936581:424,801...441,592
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:23516127 |
RGD:151361211 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
G |
Smarca2 |
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
|
|
NCBI chrNW_004936503:2,835,512...3,001,365
Ensembl chrNW_004936503:2,835,496...3,001,381
|
|
G |
Smarcb1 |
SWI/SNF related BAF chromatin remodeling complex subunit B1 |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
|
|
NCBI chrNW_004936619:1,276,239...1,308,945
Ensembl chrNW_004936619:1,275,362...1,308,913
|
|
G |
Smarce1 |
SWI/SNF related BAF chromatin remodeling complex subunit E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936490:15,638,546...15,659,372
Ensembl chrNW_004936490:15,638,526...15,659,706
|
|
G |
Smc1a |
structural maintenance of chromosomes 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936751:332,351...388,756
Ensembl chrNW_004936751:349,597...388,755
|
|
G |
Son |
SON DNA and RNA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936500:8,721,155...8,752,906
Ensembl chrNW_004936500:8,722,087...8,752,844
|
|
G |
Sox11 |
SRY-box transcription factor 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004937107:203,120...207,185
|
|
G |
Srcap |
Snf2 related CREBBP activator protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936501:13,095,690...13,131,183
Ensembl chrNW_004936501:13,096,840...13,131,183
|
|
G |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936572:5,806,897...5,851,557
Ensembl chrNW_004936572:5,806,894...5,841,550
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
ClinVar Annotator: match by term: Adenoid cystic carcinoma |
ClinVar |
|
|
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Tlk1 |
tousled like kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936509:1,315,802...1,403,993
Ensembl chrNW_004936509:1,317,534...1,404,705
|
|
G |
Top2a |
DNA topoisomerase II alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936490:15,441,463...15,465,692
Ensembl chrNW_004936490:15,441,575...15,466,978
|
|
G |
Tp53 |
tumor protein p53 |
disease_progression |
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
RGD ClinVar |
PMID:1673792 PMID:1686725 PMID:6736287 PMID:7707106 PMID:7881428 PMID:7885831 PMID:8023157 PMID:8080050 PMID:8364550 PMID:8869100 PMID:10713666 PMID:10871862 PMID:11479205 PMID:11782540 PMID:11896595 PMID:11920788 PMID:11920959 PMID:12826609 PMID:14559903 PMID:16249115 PMID:16322298 PMID:16494995 PMID:16736287 PMID:16818505 PMID:16861262 PMID:17541742 PMID:17606709 PMID:17724467 PMID:18208484 PMID:18818522 PMID:19468865 PMID:20128691 PMID:20407015 PMID:20505364 PMID:20522432 PMID:21343334 PMID:21514416 PMID:21519010 PMID:21626334 PMID:21761402 PMID:22186996 PMID:22915647 PMID:23246812 PMID:23259501 PMID:23625637 PMID:24033266 PMID:24384472 PMID:24728327 PMID:25503501 PMID:25584008 PMID:25741868 PMID:25952993 PMID:26230955 PMID:26270727 PMID:26467025 PMID:26585234 PMID:26619011 PMID:27276561 PMID:27463065 PMID:27489289 PMID:27533082 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28369373 PMID:28492532 PMID:28861920 PMID:29070607 PMID:29076966 PMID:29324801 PMID:29470806 PMID:29489754 PMID:29752822 PMID:29979965 PMID:30224644 PMID:30299350 PMID:30327374 PMID:30630526 PMID:30720243 PMID:30840781 PMID:31119730 PMID:31775759 PMID:32019277 PMID:33332384 PMID:33372952 PMID:34805717 More...
|
RGD:8547828 |
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Uhrf1 |
ubiquitin like with PHD and ring finger domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chrNW_004936588:2,863,651...2,890,116
Ensembl chrNW_004936588:2,862,367...2,888,946
|
|
G |
Vcan |
versican |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936469:2,585,142...2,688,029
Ensembl chrNW_004936469:2,585,134...2,688,029
|
|
G |
Wnt5b |
Wnt family member 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936606:1,741,500...1,854,857
Ensembl chrNW_004936606:1,838,043...1,856,095
|
|
G |
Xrn2 |
5'-3' exoribonuclease 2 |
|
ISO |
DNA:hypermethylation:3' utr: (human) |
RGD |
PMID:21692051 |
RGD:11041796 |
NCBI chrNW_004936620:4,069,956...4,145,212
Ensembl chrNW_004936620:4,069,934...4,145,745
|
|
G |
Zim2 |
zinc finger imprinted 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chrNW_004936882:533,514...539,145
|
|
|
G |
Hnf1a |
HNF1 homeobox A |
|
ISO |
|
RGD |
PMID:10489374 |
RGD:150540314 |
NCBI chrNW_004936668:62,103...81,549
Ensembl chrNW_004936668:67,535...81,505
|
|
|
G |
Birc5 |
baculoviral IAP repeat containing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16497974 |
|
NCBI chrNW_004936594:2,812,165...2,820,618
Ensembl chrNW_004936594:2,812,238...2,820,636
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18688853 |
|
NCBI chrNW_004936534:4,707,658...4,871,865
Ensembl chrNW_004936534:4,709,064...4,871,023
|
|
G |
Card11 |
caspase recruitment domain family member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936823:580,438...621,298
Ensembl chrNW_004936823:581,955...621,208
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936473:23,321,167...23,323,075
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936490:15,575,764...15,579,766
Ensembl chrNW_004936490:15,575,764...15,579,757
|
|
G |
Cd274 |
CD274 molecule |
disease_progression |
ISO |
|
RGD |
PMID:27418641 |
RGD:41412177 |
NCBI chrNW_004936539:132,870...145,288
Ensembl chrNW_004936539:132,868...143,602
|
|
G |
Cd28 |
CD28 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936631:335,411...363,407
Ensembl chrNW_004936631:335,411...363,407
|
|
G |
Cd68 |
CD68 molecule |
disease_progression |
ISO |
protein:increased expression:lymph node tumor (human) |
RGD |
PMID:23557330 |
RGD:42721976 |
NCBI chrNW_004936595:858,289...861,131
|
|
G |
Cd80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:10590132 |
RGD:6902938 |
NCBI chrNW_004936536:6,462,080...6,483,450
|
|
G |
Cd86 |
CD86 molecule |
|
ISO |
|
RGD |
PMID:10590132 |
RGD:6902938 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Csnk1a1 |
casein kinase 1 alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936504:5,351,354...5,394,856
Ensembl chrNW_004936504:5,351,029...5,396,034
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936485:17,966,993...18,021,191
|
|
G |
Csnk2b |
casein kinase 2 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936727:1,857,596...1,862,551
Ensembl chrNW_004936727:1,857,596...1,862,002
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
|
|
G |
Fas |
Fas cell surface death receptor |
susceptibility |
ISO |
protein:increased expression:peripheral blood mononuclear cell: DNA:polymorphism:promoter: -670 G>A(human) |
RGD |
PMID:7513372 PMID:17962369 |
RGD:11049147 RGD:11049453 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Foxp3 |
forkhead box P3 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23797717 PMID:23962110 |
RGD:38456007 |
NCBI chrNW_004936721:1,118,376...1,125,282
Ensembl chrNW_004936721:1,118,782...1,132,308
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936679:388,500...588,518
Ensembl chrNW_004936679:387,387...443,880
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936484:6,780,692...6,800,883
Ensembl chrNW_004936484:6,780,692...6,800,966
|
|
G |
Gpr183 |
G protein-coupled receptor 183 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936472:11,196,567...11,198,890
Ensembl chrNW_004936472:11,186,267...11,198,832
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936478:2,970,261...2,980,277
Ensembl chrNW_004936478:2,970,468...2,980,381
|
|
G |
Icos |
inducible T cell costimulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936631:562,650...572,263
Ensembl chrNW_004936631:551,394...570,804
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:8800741 PMID:23962110 |
RGD:10755707 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936586:3,522,614...3,676,070
Ensembl chrNW_004936586:3,525,933...3,674,061
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:8704212 PMID:23962110 |
RGD:11049460 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23962110 |
|
NCBI chrNW_004936662:1,594,953...1,599,625
Ensembl chrNW_004936662:1,594,953...1,599,625
|
|
G |
Il5 |
interleukin 5 |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:16425276 |
RGD:11354942 |
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:10374863 |
RGD:11060275 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936633:1,565,293...1,580,859
Ensembl chrNW_004936633:1,564,637...1,580,859
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
DNA:missense mutations: :p.L156P, p.R172Q, p.E183G (human) |
RGD |
PMID:21821710 |
RGD:11531131 |
NCBI chrNW_004936596:3,212,593...3,224,426
Ensembl chrNW_004936596:3,212,593...3,224,048
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
disease_progression |
ISO |
mRNA:splice variants:CD4+ T cell: |
RGD |
PMID:27307595 |
RGD:11532670 |
NCBI chrNW_004936560:2,797,943...2,828,813
Ensembl chrNW_004936560:2,796,697...2,829,650
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:16707600 |
RGD:1580759 |
NCBI chrNW_004936669:1,292,016...1,334,061
Ensembl chrNW_004936669:1,292,088...1,332,428
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
disease_progression |
ISO |
|
RGD |
PMID:21586752 |
RGD:11535055 |
NCBI chrNW_004936627:73,413...82,590
Ensembl chrNW_004936627:73,413...82,590
|
|
G |
Plcg1 |
phospholipase C gamma 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936561:598,372...631,575
Ensembl chrNW_004936561:598,382...631,581
|
|
G |
Prkcb |
protein kinase C beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936501:8,410,273...8,729,238
Ensembl chrNW_004936501:8,437,715...8,728,716
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24090995 |
|
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Terf2 |
telomeric repeat binding factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17643074 |
|
NCBI chrNW_004936475:19,469,501...19,498,494
Ensembl chrNW_004936475:19,468,702...19,498,793
|
|
G |
Tlx1 |
T cell leukemia homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:1683261 PMID:1717256 |
RGD:1599439 |
NCBI chrNW_004936600:4,564,246...4,569,774
|
|
G |
Tnfsf8 |
TNF superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chrNW_004936487:4,057,637...4,081,207
Ensembl chrNW_004936487:4,057,643...4,081,207
|
|
G |
Tp73 |
tumor protein p73 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936737:171,894...211,464
Ensembl chrNW_004936737:172,467...211,464
|
|
G |
Vav1 |
vav guanine nucleotide exchange factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chrNW_004936588:4,058,312...4,107,330
Ensembl chrNW_004936588:4,058,343...4,107,109
|
|
|
G |
Alk |
ALK receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16151469 PMID:19503098 PMID:21345110 PMID:22155737 PMID:22920921 PMID:22968692 More...
|
|
NCBI chrNW_004936493:3,624,288...3,671,567
Ensembl chrNW_004936493:3,028,608...3,671,874
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17157164 |
|
NCBI chrNW_004936835:316,767...321,999
Ensembl chrNW_004936835:316,767...321,990
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
DNA:translocation |
RGD |
PMID:18987657 |
RGD:11526155 |
NCBI chrNW_004936633:1,565,293...1,580,859
Ensembl chrNW_004936633:1,564,637...1,580,859
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:12145210 |
RGD:1549449 |
NCBI chrNW_004936659:1,890,786...1,892,619
Ensembl chrNW_004936659:1,891,080...1,892,123
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17261581 |
|
NCBI chrNW_004936599:3,800,142...3,810,583
Ensembl chrNW_004936599:3,801,636...3,809,813
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22155737 |
|
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Tnfrsf8 |
TNF receptor superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10908157 PMID:17261581 |
|
NCBI chrNW_004936474:814,510...889,851
|
|
G |
Twist1 |
twist family bHLH transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22155737 |
|
NCBI chrNW_004936546:5,331,220...5,332,669
Ensembl chrNW_004936546:5,331,863...5,332,555
|
|
|
G |
Tet2 |
tet methylcytosine dioxygenase 2 |
|
ISO |
ClinVar Annotator: match by term: Angioimmunoblastic T-cell lymphoma |
ClinVar |
PMID:19797729 PMID:27210295 PMID:27276561 PMID:28337768 PMID:28492532 PMID:32518946 More...
|
|
NCBI chrNW_004936752:440,137...577,339
Ensembl chrNW_004936752:440,136...577,615
|
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Precursor B-cell acute lymphoblastic leukemia |
ClinVar |
PMID:23623386 PMID:25741868 |
|
NCBI chrNW_004936501:2,301,072...2,329,346
Ensembl chrNW_004936501:2,300,835...2,329,351
|
|
G |
Nf1 |
neurofibromin 1 |
|
ISO |
ClinVar Annotator: match by term: Precursor B-cell acute lymphoblastic leukemia |
ClinVar |
PMID:9536098 PMID:17576681 PMID:23656349 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936538:3,394,623...3,596,025
Ensembl chrNW_004936538:3,398,222...3,595,261
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia |
ClinVar |
PMID:8621495 PMID:12640141 PMID:16987884 PMID:25741868 PMID:28492532 PMID:28811308 PMID:31970404 More...
|
|
NCBI chrNW_004936533:5,411,949...5,459,693
Ensembl chrNW_004936533:5,411,848...5,459,693
|
|
|
G |
Aicda |
activation induced cytidine deaminase |
disease_progression |
ISO |
|
RGD |
PMID:21133730 |
RGD:11039455 |
NCBI chrNW_004936870:25,039...34,601
Ensembl chrNW_004936870:25,039...34,601
|
|
G |
Apoe |
apolipoprotein E |
disease_progression |
ISO |
|
RGD |
PMID:18784741 |
RGD:11040549 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17968022 |
|
NCBI chrNW_004936551:359,134...534,672
Ensembl chrNW_004936551:359,362...532,211
|
|
G |
Bcl11a |
BCL11 transcription factor A |
|
ISO |
DNA:translocation:5' utr: (human) |
RGD |
PMID:11719382 |
RGD:11100004 |
NCBI chrNW_004936491:6,021,340...6,118,103
Ensembl chrNW_004936491:6,021,343...6,118,568
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment no_association severity |
ISO |
DNA:snp:promoter:g.-938C>A (human) CTD Direct Evidence: marker/mechanism protein:increased expression:B cell (human) |
RGD CTD |
PMID:16960146 PMID:17296974 PMID:17959858 PMID:20001236 PMID:21750559 PMID:23770605 More...
|
RGD:11522735 RGD:11526104 RGD:11526105 RGD:11526110 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bmf |
Bcl2 modifying factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chrNW_004936471:3,573,437...3,594,438
Ensembl chrNW_004936471:3,577,221...3,594,981
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:12068308 PMID:12198537 PMID:12692057 PMID:12960123 PMID:14612909 PMID:14679157 PMID:14688025 PMID:15035987 PMID:16187918 PMID:17096326 PMID:17119447 PMID:17311103 PMID:17704260 PMID:18039235 PMID:18060073 PMID:18368129 PMID:18413255 PMID:18794803 PMID:19206169 PMID:19376813 PMID:19383316 PMID:19537845 PMID:19913317 PMID:20350999 PMID:20619739 PMID:21062266 PMID:21129611 PMID:21639808 PMID:22048237 PMID:22310681 PMID:22495831 PMID:22663011 PMID:22972589 PMID:23352452 PMID:23680146 PMID:24033266 PMID:24451042 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:28832562 PMID:29453417 PMID:29595366 More...
|
|
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G |
Btk |
Bruton tyrosine kinase |
treatment |
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia |
RGD ClinVar |
PMID:23045577 PMID:24869598 PMID:25741868 PMID:28492532 |
RGD:11040699 |
NCBI chrNW_004936813:429,400...467,481
Ensembl chrNW_004936813:429,224...463,441
|
|
G |
Cbl |
Cbl proto-oncogene |
severity |
ISO |
DNA:hypophosphorylation:CD5+ B cell: mRNA,protein:increased expression:CD5+ B cell: |
RGD |
PMID:17804547 |
RGD:11038803 |
NCBI chrNW_004936542:4,136,389...4,235,746
Ensembl chrNW_004936542:4,136,511...4,228,288
|
|
G |
Ccdc50 |
coiled-coil domain containing 50 |
|
ISO |
|
RGD |
PMID:19641524 |
RGD:9685139 |
NCBI chrNW_004936900:495,551...563,184
Ensembl chrNW_004936900:495,547...556,316
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20616215 |
RGD:5490532 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
mouse-human chimeric gene in human |
RGD |
PMID:20882050 |
RGD:11352235 |
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G |
Cd5 |
CD5 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18006695 |
|
NCBI chrNW_004936581:1,854,166...1,866,843
Ensembl chrNW_004936581:1,854,460...1,873,142
|
|
G |
Cd79b |
CD79b molecule |
|
ISO |
protein:decreased expression:B lymphocyte, cell surface (human) mRNA, protein:splice variants, alternative forms:exon 3 (human) DNA:polymorphism:multiple (human) |
RGD |
PMID:9269755 PMID:10090943 PMID:10552962 |
RGD:11250403 RGD:151665190 RGD:151665202 |
NCBI chrNW_004936541:4,534,233...4,537,448
Ensembl chrNW_004936541:4,534,246...4,537,590
|
|
G |
Cd86 |
CD86 molecule |
severity |
ISO |
protein:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:25179679 |
RGD:11354969 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20062064 |
|
NCBI chrNW_004936483:17,216,288...17,296,430
Ensembl chrNW_004936483:17,216,213...17,294,534
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
protein:increased expression:T cell |
RGD |
PMID:15914560 PMID:16094420 |
RGD:11344923 RGD:11352246 |
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
|
ISO |
|
RGD |
PMID:18077792 |
RGD:11251735 |
NCBI chrNW_004936927:134,770...144,057
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
|
ISO |
mRNA:decreased expression: B cell |
RGD |
PMID:15467427 |
RGD:9589146 |
NCBI chrNW_004936485:19,547,836...19,570,716
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
severity |
ISO |
DNA:SNP: :p.K751Q (rs13181) (human) |
RGD |
PMID:19484764 PMID:22739018 |
RGD:11252203 RGD:11252204 |
NCBI chrNW_004936706:1,816,561...1,829,638
Ensembl chrNW_004936706:1,816,571...1,829,692
|
|
G |
Farp2 |
FERM, ARH/RhoGEF and pleckstrin domain protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20062064 |
|
NCBI chrNW_004936745:427,093...504,653
Ensembl chrNW_004936745:426,846...504,672
|
|
G |
Fas |
Fas cell surface death receptor |
disease_progression |
ISO |
|
RGD |
PMID:12901972 |
RGD:11049461 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:25741868 PMID:26619011 |
|
NCBI chrNW_004936689:2,261,163...2,449,951
Ensembl chrNW_004936689:2,259,477...2,344,764
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:12835555 PMID:16329078 PMID:16372351 PMID:16835863 PMID:17211612 PMID:17384584 PMID:18042262 PMID:19213030 PMID:19255327 PMID:19773371 PMID:20859122 PMID:20937837 PMID:21438134 PMID:21495179 PMID:21850009 PMID:22256804 PMID:22499344 PMID:22683711 PMID:22726224 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24224811 PMID:24390138 PMID:25157968 PMID:25326635 PMID:25741868 PMID:26619011 PMID:27283355 PMID:27444071 PMID:28492532 PMID:29493581 PMID:30191474 PMID:31775759 PMID:32732226 PMID:33027564 PMID:34958143 PMID:168335863 More...
|
|
NCBI chrNW_004936888:375,372...378,125
Ensembl chrNW_004936888:375,377...377,958
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
severity |
ISO |
|
RGD |
PMID:7658704 |
RGD:11354983 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Ifng |
interferon gamma |
susceptibility |
ISO |
DNA:polymorphism: :847A>T(human) |
RGD |
PMID:19757192 |
RGD:10755703 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Il10 |
interleukin 10 |
no_association disease_progression |
ISO |
DNA:SNPs: :rs1800890, rs4072227, rs17015865 (human) DNA:SNPs: :multiple protein:increased expression:serum |
RGD |
PMID:10638947 PMID:19573080 PMID:22945689 |
RGD:11041895 RGD:11049165 RGD:11049174 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18006695 |
|
NCBI chrNW_004936557:5,765,093...5,769,853
Ensembl chrNW_004936557:5,765,093...5,769,853
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:19074885 |
RGD:11051968 |
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
severity |
ISO |
protein:decreased expression:plasma: DNA:SNP:promoter:-511C>T (human) |
RGD |
PMID:10870116 PMID:18271063 |
RGD:11051967 RGD:11522755 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:decreased expression:plasma: |
RGD |
PMID:10870116 |
RGD:11522755 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:plasma: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10870116 PMID:18006695 |
RGD:11522755 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Irf4 |
interferon regulatory factor 4 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12079517 PMID:12393648 PMID:18758461 |
RGD:11526160 RGD:11530024 |
NCBI chrNW_004936633:1,565,293...1,580,859
Ensembl chrNW_004936633:1,564,637...1,580,859
|
|
G |
Itga4 |
integrin subunit alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21093051 |
|
NCBI chrNW_004936509:10,215,283...10,293,653
Ensembl chrNW_004936509:10,215,283...10,292,252
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:2278970 PMID:3122217 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 More...
|
|
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chrNW_004936818:453,635...569,194
Ensembl chrNW_004936818:453,635...567,469
|
|
G |
LOC101955076 |
low affinity immunoglobulin gamma Fc region receptor III-A |
no_association |
ISO |
DNA:SNP:exon:p.F158V (rs396991) (human) |
RGD |
PMID:14563637 |
RGD:11352260 |
NCBI chrNW_004937131:42,523...49,533
|
|
G |
LOC101971027 |
neuroendocrine secretory protein 55 |
disease_progression |
ISO |
DNA:polymorphism:393T>C (human) |
RGD |
PMID:17020971 |
RGD:1601379 |
NCBI chrNW_004936530:1,353,432...1,407,437
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:12835555 PMID:16329078 PMID:16372351 PMID:16835863 PMID:17211612 PMID:17384584 PMID:18042262 PMID:19213030 PMID:19255327 PMID:19773371 PMID:20859122 PMID:20937837 PMID:21438134 PMID:21495179 PMID:21850009 PMID:22256804 PMID:22499344 PMID:22683711 PMID:22726224 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24224811 PMID:24390138 PMID:25157968 PMID:25326635 PMID:25741868 PMID:26619011 PMID:27283355 PMID:27444071 PMID:28492532 PMID:29493581 PMID:30191474 PMID:31775759 PMID:32732226 PMID:33027564 PMID:34958143 PMID:168335863 More...
|
|
NCBI chrNW_004936888:379,622...397,647
Ensembl chrNW_004936888:382,062...402,083
|
|
G |
Ms4a1 |
membrane spanning 4-domains A1 |
|
ISO |
|
RGD |
PMID:19911856 |
RGD:2316994 |
NCBI chrNW_004936581:2,466,294...2,477,530
Ensembl chrNW_004936581:2,466,312...2,477,530
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16706930 |
|
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:21179087 PMID:22931316 PMID:23215570 PMID:23355535 PMID:26619011 PMID:28492532 More...
|
|
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 More...
|
|
NCBI chrNW_004936627:73,413...82,590
Ensembl chrNW_004936627:73,413...82,590
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11003599 |
|
NCBI chrNW_004936558:3,106,819...3,149,689
Ensembl chrNW_004936558:3,108,283...3,149,765
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
severity |
ISO |
protein:increased expression:B cell (human) |
RGD |
PMID:12673718 |
RGD:11541127 |
NCBI chrNW_004936541:4,873,459...4,919,787
Ensembl chrNW_004936541:4,873,182...4,937,500
|
|
G |
Plcg2 |
phospholipase C gamma 2 |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia |
ClinVar |
PMID:24869598 PMID:28492532 |
|
NCBI chrNW_004936475:29,248,533...29,377,335
Ensembl chrNW_004936475:29,248,516...29,377,206
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chrNW_004936497:4,985,995...4,986,720
|
|
G |
Polb |
DNA polymerase beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18006695 |
|
NCBI chrNW_004936785:324,655...350,496
Ensembl chrNW_004936785:323,941...350,539
|
|
G |
Ppp2r5c |
protein phosphatase 2 regulatory subunit B'gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16038780 |
|
NCBI chrNW_004936835:54,478...192,486
Ensembl chrNW_004936835:96,930...192,756
|
|
G |
Prame |
PRAME nuclear receptor transcriptional regulator |
|
ISO |
protein:increased expression:mononuclear cell (human) |
RGD |
PMID:16620968 |
RGD:11535021 |
NCBI chrNW_004936619:1,748,337...1,751,748
|
|
G |
Prkd2 |
protein kinase D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18758461 |
|
NCBI chrNW_004936664:524,532...551,451
Ensembl chrNW_004936664:522,910...551,469
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16314473 |
|
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Ptpn11 |
protein tyrosine phosphatase non-receptor type 11 |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:12161469 PMID:12717436 PMID:14644997 PMID:14982869 PMID:15385933 PMID:15710330 PMID:15834506 PMID:15928039 PMID:16358218 PMID:17177198 PMID:17972951 PMID:18759865 PMID:19047918 PMID:19179468 PMID:24033266 PMID:25097206 PMID:25395418 PMID:25741868 PMID:26619011 PMID:26918529 PMID:27069254 PMID:28074573 PMID:28098151 PMID:28492532 PMID:30868567 PMID:30896080 More...
|
|
NCBI chrNW_004936668:2,602,261...2,687,903
Ensembl chrNW_004936668:2,628,706...2,682,448
|
|
G |
Qpct |
glutaminyl-peptide cyclotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chrNW_004936663:929,737...959,458
Ensembl chrNW_004936663:929,363...959,668
|
|
G |
Rbl2 |
RB transcriptional corepressor like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16038780 |
|
NCBI chrNW_004936475:6,087,055...6,140,012
Ensembl chrNW_004936475:6,086,584...6,144,067
|
|
G |
Sf3b1 |
splicing factor 3b subunit 1 |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:23634996 PMID:25741868 PMID:26619011 |
|
NCBI chrNW_004936506:1,749,591...1,790,860
Ensembl chrNW_004936506:1,749,563...1,791,739
|
|
G |
Sf3b2 |
splicing factor 3b subunit 2 |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:26619011 |
|
NCBI chrNW_004936599:3,477,882...3,494,366
Ensembl chrNW_004936599:3,477,589...3,494,354
|
|
G |
Sp140 |
SP140 nuclear body protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18758461 |
|
NCBI chrNW_004936525:6,239,566...6,301,657
|
|
G |
Tert |
telomerase reverse transcriptase |
disease_progression |
ISO |
|
RGD |
PMID:17344921 |
RGD:11038662 |
NCBI chrNW_004936815:468,987...492,666
Ensembl chrNW_004936815:469,020...491,697
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16904380 |
|
NCBI chrNW_004936784:696,738...728,385
Ensembl chrNW_004936784:696,713...728,543
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:21812019 |
RGD:5685033 |
NCBI chrNW_004936620:2,563,900...2,568,117
|
|
G |
Tnf |
tumor necrosis factor |
disease_progression |
ISO |
protein:increased expression:bone marrow, blood, lymphocyte |
RGD |
PMID:12010662 PMID:22945689 |
RGD:10449463 RGD:11041895 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf11a |
TNF receptor superfamily member 11a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16270354 |
|
NCBI chrNW_004936497:2,944,841...2,986,113
Ensembl chrNW_004936497:2,945,010...2,995,207
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16270354 |
|
NCBI chrNW_004936747:1,255,803...1,288,252
Ensembl chrNW_004936747:1,255,803...1,288,252
|
|
G |
Tnfsf13 |
TNF superfamily member 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15488762 |
RGD:1549466 |
NCBI chrNW_004936595:839,877...842,962
Ensembl chrNW_004936595:839,877...842,962
|
|
G |
Tnfsf8 |
TNF superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chrNW_004936487:4,057,637...4,081,207
Ensembl chrNW_004936487:4,057,643...4,081,207
|
|
G |
Topbp1 |
DNA topoisomerase II binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18006695 |
|
NCBI chrNW_004936529:6,788,713...6,841,824
Ensembl chrNW_004936529:6,788,187...6,841,888
|
|
G |
Tp53 |
tumor protein p53 |
disease_progression |
ISO |
DNA:deletion: : ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
RGD ClinVar |
PMID:253702 PMID:1565143 PMID:1565144 PMID:1631137 PMID:1679237 PMID:1683921 PMID:1978757 PMID:2046748 PMID:2531845 PMID:2554494 PMID:7478555 PMID:7651740 PMID:7732013 PMID:7737263 PMID:7791795 PMID:7887414 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8276238 PMID:8308926 PMID:8423216 PMID:8425176 PMID:8479749 PMID:8527048 PMID:8649776 PMID:8718514 PMID:8825920 PMID:9150393 PMID:9242456 PMID:9290701 PMID:9364015 PMID:9399838 PMID:9407971 PMID:9546439 PMID:9569050 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9704930 PMID:9825943 PMID:9839505 PMID:10064694 PMID:10089074 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10589545 PMID:10713666 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10867151 PMID:10922393 PMID:11051239 PMID:11139324 PMID:11180592 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11593407 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12406399 PMID:12506399 PMID:12672316 PMID:12700230 PMID:12726864 PMID:12826609 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15221755 PMID:15381368 PMID:15390294 PMID:15607980 PMID:15607981 PMID:15722483 PMID:15825182 PMID:15925506 PMID:15951970 PMID:16337994 PMID:16401470 PMID:16489069 PMID:16682957 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17170001 PMID:17308077 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17540308 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17881637 PMID:18307025 PMID:18511570 PMID:18685109 PMID:18937320 PMID:19101993 PMID:19147582 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19454241 PMID:19556618 PMID:19681600 PMID:19850740 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20505364 PMID:20516128 PMID:20522432 PMID:20593220 PMID:20693561 PMID:20805372 PMID:20878954 PMID:21056685 PMID:21059199 PMID:21113594 PMID:21115975 PMID:21118481 PMID:21159183 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21601526 PMID:21761402 PMID:22006311 PMID:22110706 PMID:22186996 PMID:22198284 PMID:22265402 PMID:22484423 PMID:22713868 PMID:22811390 PMID:22822097 PMID:22869713 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:22983585 PMID:23028800 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23263379 PMID:23484829 PMID:23538418 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24065105 PMID:24381225 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24744791 PMID:24810334 PMID:25157968 PMID:25256166 PMID:25293557 PMID:25294809 PMID:25339994 PMID:25404506 PMID:25503501 PMID:25504633 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25634208 PMID:25691460 PMID:25741868 PMID:25765855 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:26014290 PMID:26024390 PMID:26230955 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26681312 PMID:26781615 PMID:26787237 PMID:26822237 PMID:26845104 PMID:27050224 PMID:27179933 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27463065 PMID:27493922 PMID:27501770 PMID:27523101 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27813088 PMID:27873457 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28152038 PMID:28160093 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28772286 PMID:28861920 PMID:28873162 PMID:29025599 PMID:29070607 PMID:29300620 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29752822 PMID:29958926 PMID:29979965 PMID:30076369 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30322717 PMID:30327374 PMID:30583724 PMID:30630526 PMID:30709875 PMID:30816478 PMID:30840781 PMID:30918304 PMID:31105275 PMID:31119730 PMID:31127191 PMID:31168460 PMID:31296311 PMID:31300551 PMID:31494577 PMID:31533767 PMID:31748977 PMID:31775759 PMID:31881331 PMID:31882575 PMID:32000721 PMID:32126783 PMID:32164171 PMID:32179180 PMID:32187361 PMID:32295079 PMID:32371905 PMID:32817165 PMID:32906206 PMID:32959997 PMID:33245408 PMID:33300245 PMID:33372952 PMID:33471991 PMID:33633026 PMID:33674644 PMID:33818021 PMID:34026625 PMID:34240179 PMID:34308366 PMID:34793666 PMID:34994652 PMID:35033608 PMID:35127508 PMID:35820297 PMID:36168441 PMID:36988593 More...
|
RGD:11075074 |
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12446453 |
|
NCBI chrNW_004936512:5,741,836...5,800,999
Ensembl chrNW_004936512:5,740,748...5,801,109
|
|
G |
Xpo1 |
exportin 1 |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:26619011 |
|
NCBI chrNW_004936491:6,921,753...6,962,062
Ensembl chrNW_004936491:6,921,319...6,962,343
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
no_association severity |
ISO |
DNA:SNP: :p.R194W (rs1799782), p.R280H (25489) (human) DNA:SNP: :p.R399Q (rs25487) (human) |
RGD |
PMID:19484764 |
RGD:11252204 |
NCBI chrNW_004936706:752,571...783,746
Ensembl chrNW_004936706:751,108...783,777
|
|
|
G |
Aicda |
activation induced cytidine deaminase |
|
ISO |
|
RGD |
PMID:17251349 |
RGD:11039449 |
NCBI chrNW_004936870:25,039...34,601
Ensembl chrNW_004936870:25,039...34,601
|
|
G |
Bcl6 |
BCL6 transcription repressor |
|
ISO |
diffuse large B-cell lymphoma DNA:translocation:promoter,CDS:t(3;16)(q27;p11) results in IL21R promoter fused to BCL6 coding region |
RGD |
PMID:11821949 |
RGD:1600111 |
NCBI chrNW_004936578:2,371,976...2,395,034
Ensembl chrNW_004936578:2,371,945...2,395,071
|
|
G |
Brd2 |
bromodomain containing 2 |
|
ISO |
|
RGD |
PMID:14563639 |
RGD:9586345 |
NCBI chrNW_004936476:25,807,179...25,818,914
Ensembl chrNW_004936476:25,807,163...25,818,899
|
|
G |
Btk |
Bruton tyrosine kinase |
treatment |
ISO |
human cell in a mouse model |
RGD |
PMID:25662332 PMID:28348046 |
RGD:11040764 RGD:124713554 |
NCBI chrNW_004936813:429,400...467,481
Ensembl chrNW_004936813:429,224...463,441
|
|
G |
Cbx7 |
chromobox 7 |
|
ISO |
|
RGD |
PMID:17374722 |
RGD:11352707 |
NCBI chrNW_004936492:2,411,171...2,428,484
Ensembl chrNW_004936492:2,410,308...2,428,682
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20616215 |
RGD:5490532 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Csf2 |
colony stimulating factor 2 |
treatment |
ISO |
|
RGD |
PMID:8469286 |
RGD:10450244 |
NCBI chrNW_004936647:3,081,896...3,083,864
Ensembl chrNW_004936647:3,081,896...3,083,864
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11042651 |
|
NCBI chrNW_004936490:15,142,526...15,146,375
Ensembl chrNW_004936490:15,142,808...15,144,487
|
|
G |
Eaf2 |
ELL associated factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20564326 |
|
NCBI chrNW_004936536:8,213,794...8,257,595
Ensembl chrNW_004936536:8,213,763...8,258,201
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
severity treatment |
ISO |
|
RGD MouseDO |
PMID:23982173 PMID:29456795 |
RGD:10755356 RGD:126781726 |
NCBI chrNW_004936527:5,024,077...5,069,152
Ensembl chrNW_004936527:5,024,068...5,063,939
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
diffuse large B-cell lymphoma DNA:translocation:promoter,CDS:t(3;16)(q27;p11) results in IL21R promoter fused to BCL6 coding region |
RGD |
PMID:11821949 |
RGD:1600111 |
NCBI chrNW_004936501:11,100,170...11,112,112
Ensembl chrNW_004936501:11,100,170...11,110,744
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24837469 |
|
NCBI chrNW_004936596:3,212,593...3,224,426
Ensembl chrNW_004936596:3,212,593...3,224,048
|
|
G |
Kat5 |
lysine acetyltransferase 5 |
severity |
ISO |
|
RGD |
PMID:17728759 |
RGD:9588481 |
NCBI chrNW_004936599:3,767,526...3,775,416
Ensembl chrNW_004936599:3,766,242...3,776,128
|
|
G |
Lgals1 |
galectin 1 |
|
ISO |
protein:increased expression:primary tumor (rat) |
RGD |
PMID:16733672 |
RGD:2316550 |
NCBI chrNW_004936492:3,407,704...3,411,197
Ensembl chrNW_004936492:3,407,049...3,411,222
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14633661 |
|
NCBI chrNW_004936627:73,413...82,590
Ensembl chrNW_004936627:73,413...82,590
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14654083 |
|
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Ptpn1 |
protein tyrosine phosphatase non-receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24531327 |
|
NCBI chrNW_004936514:4,065,455...4,083,847
Ensembl chrNW_004936514:4,068,238...4,084,009
|
|
G |
Tnfsf8 |
TNF superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chrNW_004936487:4,057,637...4,081,207
Ensembl chrNW_004936487:4,057,643...4,081,207
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
|
ISO |
|
RGD |
PMID:10202049 |
RGD:2317349 |
NCBI chrNW_004936588:3,844,924...3,847,218
|
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
treatment |
ISO |
|
RGD |
PMID:21481795 |
RGD:11038814 |
NCBI chrNW_004936487:17,690,206...17,819,619
Ensembl chrNW_004936487:17,690,968...17,819,669
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35687267 |
|
NCBI chrNW_004936546:3,737,908...3,783,492
Ensembl chrNW_004936546:3,737,851...3,783,588
|
|
G |
Atf7ip |
activating transcription factor 7 interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24413735 |
|
NCBI chrNW_004936587:2,922,855...3,026,773
Ensembl chrNW_004936587:2,919,666...3,026,837
|
|
G |
Bcl2l1 |
BCL2 like 1 |
severity |
ISO |
|
RGD |
PMID:18216295 |
RGD:11531108 |
NCBI chrNW_004936485:18,654,046...18,707,324
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
|
ISO |
BCR/ABL fusion |
RGD |
PMID:9310467 |
RGD:41404633 |
NCBI chrNW_004936619:288,377...432,297
Ensembl chrNW_004936619:288,340...432,315
|
|
G |
Brd2 |
bromodomain containing 2 |
|
ISO |
|
RGD |
PMID:14563639 |
RGD:9586345 |
NCBI chrNW_004936476:25,807,179...25,818,914
Ensembl chrNW_004936476:25,807,163...25,818,899
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24154679 |
|
NCBI chrNW_004936560:42,561...45,748
Ensembl chrNW_004936560:42,537...45,807
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
mRNA:increased expression:B cell (mouse) |
RGD |
PMID:23169640 |
RGD:11353783 |
Ensembl chrNW_004936599:973,838...983,316
|
|
G |
Crlf2 |
cytokine receptor like factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24141364 |
|
NCBI chrNW_004936644:3,866,973...3,872,749
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15217836 PMID:24413735 PMID:25807284 |
|
NCBI chrNW_004936587:5,328,467...5,457,260
Ensembl chrNW_004936587:5,330,665...5,457,264
|
|
G |
F13a1 |
coagulation factor XIII A chain |
|
ISO |
protein:increased expression:B lymphoblast: |
RGD |
PMID:16894461 |
RGD:11041855 |
NCBI chrNW_004936534:6,199,066...6,360,374
Ensembl chrNW_004936534:6,199,066...6,361,476
|
|
G |
F3 |
coagulation factor III, tissue factor |
treatment |
ISO |
|
RGD |
PMID:19874310 |
RGD:11341694 |
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
|
|
G |
Fh |
fumarate hydratase |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936526:8,936,096...8,965,155
Ensembl chrNW_004936526:8,935,991...8,965,367
|
|
G |
Flt3 |
fms related receptor tyrosine kinase 3 |
|
ISO |
mRNA,protein:increased expression:bone marrow: |
RGD |
PMID:8562934 |
RGD:11049466 |
NCBI chrNW_004936472:23,169,967...23,239,178
Ensembl chrNW_004936472:23,170,470...23,256,904
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24141364 |
|
NCBI chrNW_004936484:6,780,692...6,800,883
Ensembl chrNW_004936484:6,780,692...6,800,966
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35687267 |
|
NCBI chrNW_004936843:658,058...672,662
Ensembl chrNW_004936843:657,979...672,700
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
disease_progression |
ISO |
DNA:mutations: : CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:22699455 PMID:24141364 |
RGD:11075072 |
NCBI chrNW_004936686:1,459,582...1,556,478
Ensembl chrNW_004936686:1,462,145...1,556,451
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
|
RGD |
PMID:15368290 |
RGD:7241068 |
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
|
RGD |
PMID:20585039 PMID:21818355 PMID:25006123 |
RGD:11526159 RGD:11530020 RGD:11530030 |
NCBI chrNW_004936633:1,565,293...1,580,859
Ensembl chrNW_004936633:1,564,637...1,580,859
|
|
G |
Irf8 |
interferon regulatory factor 8 |
|
ISO |
|
RGD |
PMID:20585039 |
RGD:11530030 |
NCBI chrNW_004936641:2,608,109...2,622,446
Ensembl chrNW_004936641:2,608,100...2,622,409
|
|
G |
Isx |
intestine specific homeobox |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35687267 |
|
NCBI chrNW_004936492:5,245,211...5,265,419
Ensembl chrNW_004936492:5,245,211...5,265,419
|
|
G |
Mga |
MAX dimerization protein MGA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24413735 |
|
NCBI chrNW_004936471:4,946,770...5,073,925
Ensembl chrNW_004936471:4,946,124...5,073,849
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
disease_progression |
ISO |
mRNA:splice variants:cds: |
RGD |
PMID:21853052 |
RGD:11532669 |
NCBI chrNW_004936560:2,797,943...2,828,813
Ensembl chrNW_004936560:2,796,697...2,829,650
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
|
RGD |
PMID:22120021 |
RGD:7207416 |
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
|
|
G |
Pax5 |
paired box 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24013638 PMID:30643249 |
|
NCBI chrNW_004936524:4,700,815...4,887,035
Ensembl chrNW_004936524:4,700,841...4,887,106
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
treatment |
ISO |
|
RGD |
PMID:22447844 |
RGD:11075097 |
NCBI chrNW_004936482:16,804,129...16,853,539
Ensembl chrNW_004936482:16,807,569...16,853,587
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936565:1,596,227...1,746,706
Ensembl chrNW_004936565:1,597,593...1,746,846
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
onset |
ISO |
DNA:amplification |
RGD |
PMID:21822204 |
RGD:6482828 |
NCBI chrNW_004936500:7,621,328...7,710,909
Ensembl chrNW_004936500:7,486,954...7,709,504
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19796711 |
|
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified |
ClinVar |
PMID:25741868 PMID:26080840 PMID:26295973 PMID:28492532 |
|
NCBI chrNW_004936588:579,816...601,033
Ensembl chrNW_004936588:579,816...603,654
|
|
G |
Sufu |
SUFU negative regulator of hedgehog signaling |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936600:3,270,662...3,381,722
Ensembl chrNW_004936600:3,268,260...3,381,781
|
|
G |
Tcf3 |
transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19246562 |
|
NCBI chrNW_004936588:884,817...913,052
Ensembl chrNW_004936588:884,789...912,753
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35687267 |
|
NCBI chrNW_004936576:2,537,702...2,555,790
Ensembl chrNW_004936576:2,537,702...2,555,785
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
treatment |
ISO |
|
RGD |
PMID:19874310 |
RGD:11341694 |
NCBI chrNW_004936506:10,103,120...10,172,800
Ensembl chrNW_004936506:10,103,139...10,171,863
|
|
G |
Tnfsf13 |
TNF superfamily member 13 |
|
ISO |
|
RGD |
PMID:15488762 |
RGD:1549466 |
NCBI chrNW_004936595:839,877...842,962
Ensembl chrNW_004936595:839,877...842,962
|
|
G |
Tnfsf8 |
TNF superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chrNW_004936487:4,057,637...4,081,207
Ensembl chrNW_004936487:4,057,643...4,081,207
|
|
G |
Tp53 |
tumor protein p53 |
disease_progression |
ISO |
DNA:mutations: : |
RGD |
PMID:22699455 |
RGD:11075072 |
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: Pre-B-cell acute lymphoblastic leukemia |
ClinVar |
PMID:8621495 PMID:12640141 PMID:16987884 PMID:25741868 PMID:28492532 PMID:28811308 PMID:31970404 More...
|
|
NCBI chrNW_004936533:5,411,949...5,459,693
Ensembl chrNW_004936533:5,411,848...5,459,693
|
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: Mixed phenotype acute leukemia with t(v;11q23.3) |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936533:5,411,949...5,459,693
Ensembl chrNW_004936533:5,411,848...5,459,693
|
|
|
G |
Msh6 |
mutS homolog 6 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 |
ClinVar |
PMID:22658618 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936508:4,708,661...4,728,671
Ensembl chrNW_004936508:4,708,661...4,728,787
|
|
|
G |
Bmpr1a |
bone morphogenetic protein receptor type 1A |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 |
ClinVar |
PMID:25741868 PMID:28492532 PMID:30093976 |
|
NCBI chrNW_004936804:52,435...115,289
Ensembl chrNW_004936804:48,947...115,412
|
|
G |
Palb2 |
partner and localizer of BRCA2 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 |
ClinVar |
PMID:25741868 PMID:28492532 PMID:33471991 |
|
NCBI chrNW_004936501:8,246,927...8,273,258
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936565:1,596,227...1,746,706
Ensembl chrNW_004936565:1,597,593...1,746,846
|
|
G |
Recql4 |
RecQ like helicase 4 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 |
ClinVar |
PMID:10678659 PMID:12734318 PMID:12838562 PMID:12952869 PMID:15897384 PMID:15964893 PMID:18716613 PMID:20113479 PMID:25741868 PMID:28492532 PMID:29367366 PMID:31829210 More...
|
|
NCBI chrNW_004936470:7,755,253...7,761,705
|
|
|
G |
Cbl |
Cbl proto-oncogene |
|
ISO |
ClinVar Annotator: match by term: B lymphoblastic leukemia lymphoma with hyperdiploidy |
ClinVar |
PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936542:4,136,389...4,235,746
Ensembl chrNW_004936542:4,136,511...4,228,288
|
|
|
G |
Sdha |
succinate dehydrogenase complex flavoprotein subunit A |
|
ISO |
ClinVar Annotator: match by term: B-lymphoblastic leukemia/lymphoma with hypodiploidy |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936815:1,148,963...1,167,585
Ensembl chrNW_004936815:1,148,963...1,167,568
|
|
|
G |
A4galt |
alpha 1,4-galactosyltransferase (P1PK blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11482875 |
|
NCBI chrNW_004936718:594,462...630,926
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936474:11,148,857...11,197,312
|
|
G |
Bbc3 |
BCL2 binding component 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18573879 |
|
NCBI chrNW_004936664:962,115...966,797
|
|
G |
Brca1 |
BRCA1 DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Burkitt lymphoma |
ClinVar |
PMID:17262179 PMID:25741868 PMID:26467025 PMID:28492532 PMID:31911673 PMID:33471991 PMID:36881271 More...
|
|
NCBI chrNW_004936490:17,735,444...17,801,456
|
|
G |
Btk |
Bruton tyrosine kinase |
ameliorates treatment |
ISO |
Human cell line in a mouse model mRNA:increased expression:multiple (human) |
RGD |
PMID:28474336 PMID:30546948 |
RGD:124713565 RGD:124715474 |
NCBI chrNW_004936813:429,400...467,481
Ensembl chrNW_004936813:429,224...463,441
|
|
G |
Calr |
calreticulin |
treatment |
ISO |
human cells and recombinant protein in a mouse model human cell line and recombinant protein in a mouse model |
RGD |
PMID:9858521 PMID:10961892 |
RGD:150521687 RGD:150521702 |
NCBI chrNW_004936659:1,994,695...1,999,070
Ensembl chrNW_004936659:1,994,648...1,999,430
|
|
G |
Cct6b |
chaperonin containing TCP1 subunit 6B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936538:228,595...279,375
Ensembl chrNW_004936538:244,835...280,048
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
human cell line in a mouse model |
RGD |
PMID:9192773 |
RGD:11520790 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd79b |
CD79b molecule |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:17374736 |
RGD:151665154 |
NCBI chrNW_004936541:4,534,233...4,537,448
Ensembl chrNW_004936541:4,534,246...4,537,590
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936778:375,800...390,764
Ensembl chrNW_004936778:375,800...390,554
|
|
G |
Gna13 |
G protein subunit alpha 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936541:7,583,911...7,623,485
Ensembl chrNW_004936541:7,583,216...7,623,375
|
|
G |
Id3 |
inhibitor of DNA binding 3, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143595 PMID:23143597 |
|
NCBI chrNW_004936474:8,758,098...8,759,684
Ensembl chrNW_004936474:8,758,030...8,759,823
|
|
G |
Mllt11 |
MLLT11 transcription factor 7 cofactor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31587870 |
|
NCBI chrNW_004936580:1,274,658...1,283,505
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
ClinVar Annotator: match by term: Burkitt lymphoma |
OMIM ClinVar |
PMID:8220424 PMID:25157968 PMID:27993330 |
|
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
|
|
G |
Pbx1 |
PBX homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1967982 PMID:17244677 |
|
NCBI chrNW_004936481:20,200,236...20,440,623
Ensembl chrNW_004936481:20,203,405...20,440,629
|
|
G |
Pc |
pyruvate carboxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936599:2,677,770...2,793,033
Ensembl chrNW_004936599:2,677,583...2,793,197
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936480:1,188,408...1,273,210
Ensembl chrNW_004936480:1,188,183...1,273,537
|
|
G |
Ret |
ret proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936617:2,927,185...2,980,594
Ensembl chrNW_004936617:2,927,155...2,980,602
|
|
G |
Sall3 |
spalt like transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936616:903,220...922,635
Ensembl chrNW_004936616:901,076...922,641
|
|
G |
Smarca4 |
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chrNW_004936659:1,152,846...1,246,718
Ensembl chrNW_004936659:1,169,792...1,249,213
|
|
G |
Tcf3 |
transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1967982 PMID:17244677 |
|
NCBI chrNW_004936588:884,817...913,052
Ensembl chrNW_004936588:884,789...912,753
|
|
|
G |
Btk |
Bruton tyrosine kinase |
ameliorates |
ISO |
|
RGD |
PMID:28552327 |
RGD:124715478 |
NCBI chrNW_004936813:429,400...467,481
Ensembl chrNW_004936813:429,224...463,441
|
|
G |
Cd79b |
CD79b molecule |
treatment |
ISO |
|
RGD |
PMID:28619981 |
RGD:151665208 |
NCBI chrNW_004936541:4,534,233...4,537,448
Ensembl chrNW_004936541:4,534,246...4,537,590
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
DNA:SNP:promoter:-1082G>A (human) |
RGD |
PMID:22628023 |
RGD:7364831 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
treatment |
ISO |
|
RGD |
PMID:28619981 |
RGD:151665208 |
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
|
G |
Ctcf |
CCCTC-binding factor |
disease_progression |
ISO |
mRNA, protein:increased expression:bone marrow, blood (human) |
RGD |
PMID:24393203 |
RGD:151356757 |
NCBI chrNW_004936475:17,987,137...18,031,733
Ensembl chrNW_004936475:17,987,156...18,031,760
|
|
|
G |
Ak3 |
adenylate kinase 3 |
|
ISO |
protein:increased expression:peripheral blood mononuclear cell |
RGD |
PMID:27078856 |
RGD:13842476 |
NCBI chrNW_004936503:497,391...517,011
Ensembl chrNW_004936503:496,965...516,888
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
|
ISO |
mRNA:increased expression: (human) |
RGD |
PMID:36595475 |
RGD:401901275 |
NCBI chrNW_004936595:5,373,645...5,542,915
Ensembl chrNW_004936595:5,373,476...5,543,073
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:12068308 PMID:12198537 PMID:12960123 PMID:14612909 PMID:14679157 PMID:14688025 PMID:15035987 PMID:16187918 PMID:17096326 PMID:17119447 PMID:17311103 PMID:18368129 PMID:18794803 PMID:19206169 PMID:19383316 PMID:19537845 PMID:19913317 PMID:20350999 PMID:20619739 PMID:21129611 PMID:21639808 PMID:22048237 PMID:22310681 PMID:22495831 PMID:22663011 PMID:22972589 PMID:23352452 PMID:24033266 PMID:24451042 PMID:25157968 PMID:26619011 PMID:28492532 PMID:28832562 PMID:29453417 PMID:29595366 More...
|
|
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:9450802 |
RGD:11522717 |
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G |
Cd79b |
CD79b molecule |
|
ISO |
DNA:mutation:multiple (human) protein:decreased expression:blood, B cell (human) mRNA, protein:splice variants, alternative forms:exon 3 (human) protein:decreased expression:peripheral blood cells (human) |
RGD |
PMID:10090943 PMID:10329919 PMID:10516749 PMID:10753858 |
RGD:11531139 RGD:151665125 RGD:151665152 RGD:151665190 |
NCBI chrNW_004936541:4,534,233...4,537,448
Ensembl chrNW_004936541:4,534,246...4,537,590
|
|
G |
Cd86 |
CD86 molecule |
|
ISO |
DNA:hypermethylation (human) |
RGD |
PMID:23154584 |
RGD:11354975 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:25741868 PMID:26619011 |
|
NCBI chrNW_004936689:2,261,163...2,449,951
Ensembl chrNW_004936689:2,259,477...2,344,764
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:12835555 PMID:16329078 PMID:16372351 PMID:16835863 PMID:17211612 PMID:17384584 PMID:18042262 PMID:19213030 PMID:19255327 PMID:19773371 PMID:20859122 PMID:20937837 PMID:21438134 PMID:21495179 PMID:21850009 PMID:22256804 PMID:22499344 PMID:22683711 PMID:22726224 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24224811 PMID:24390138 PMID:25157968 PMID:25326635 PMID:25741868 PMID:26619011 PMID:27283355 PMID:27444071 PMID:28492532 PMID:29493581 PMID:30191474 PMID:31775759 PMID:32732226 PMID:33027564 PMID:34958143 PMID:168335863 More...
|
|
NCBI chrNW_004936888:375,372...378,125
Ensembl chrNW_004936888:375,377...377,958
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21911837 |
RGD:11354912 |
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
|
|
G |
Irf4 |
interferon regulatory factor 4 |
disease_progression |
ISO |
DNA:SNPs:3' utr:multiple DNA:SNP: :rs872071 (human) DNA:missense mutation:exon:p.L116R (human) |
RGD |
PMID:20090783 PMID:20123861 PMID:20731705 PMID:21791429 PMID:23897826 PMID:23926303 More...
|
RGD:11526156 RGD:11526158 RGD:11530021 RGD:11530026 RGD:11530029 RGD:11530031 |
NCBI chrNW_004936633:1,565,293...1,580,859
Ensembl chrNW_004936633:1,564,637...1,580,859
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:2278970 PMID:3122217 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 More...
|
|
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:12835555 PMID:16329078 PMID:16372351 PMID:16835863 PMID:17211612 PMID:17384584 PMID:18042262 PMID:19213030 PMID:19255327 PMID:19773371 PMID:20859122 PMID:20937837 PMID:21438134 PMID:21495179 PMID:21850009 PMID:22256804 PMID:22499344 PMID:22683711 PMID:22726224 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24224811 PMID:24390138 PMID:25157968 PMID:25326635 PMID:25741868 PMID:26619011 PMID:27283355 PMID:27444071 PMID:28492532 PMID:29493581 PMID:30191474 PMID:31775759 PMID:32732226 PMID:33027564 PMID:34958143 PMID:168335863 More...
|
|
NCBI chrNW_004936888:379,622...397,647
Ensembl chrNW_004936888:382,062...402,083
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
disease_progression |
ISO |
|
RGD |
PMID:20956327 |
RGD:11340590 |
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:21179087 PMID:22931316 PMID:23215570 PMID:23355535 PMID:26619011 PMID:28492532 More...
|
|
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 More...
|
|
NCBI chrNW_004936627:73,413...82,590
Ensembl chrNW_004936627:73,413...82,590
|
|
G |
Pon1 |
paraoxonase 1 |
susceptibility |
ISO |
DNA:missense mutations:cds:p.L55M, p.Q192R (human) |
RGD |
PMID:26254371 |
RGD:11073982 |
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
|
|
G |
Ptpn11 |
protein tyrosine phosphatase non-receptor type 11 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:12717436 PMID:14644997 PMID:15385933 PMID:15710330 PMID:15928039 PMID:16358218 PMID:17972951 PMID:19047918 PMID:19179468 PMID:24033266 PMID:25097206 PMID:25395418 PMID:25741868 PMID:26619011 PMID:27069254 PMID:28098151 PMID:30868567 More...
|
|
NCBI chrNW_004936668:2,602,261...2,687,903
Ensembl chrNW_004936668:2,628,706...2,682,448
|
|
G |
Ptpn22 |
protein tyrosine phosphatase non-receptor type 22 |
susceptibility |
ISO |
DNA:snp:cds:p.R620W (rs2476601) (human) protein:increased expression:B cell (human) |
RGD |
PMID:22569400 PMID:23287625 |
RGD:11533998 RGD:11535006 |
NCBI chrNW_004936690:2,180,804...2,232,869
Ensembl chrNW_004936690:2,181,047...2,232,958
|
|
G |
Sf3b1 |
splicing factor 3b subunit 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:26619011 |
|
NCBI chrNW_004936506:1,749,591...1,790,860
Ensembl chrNW_004936506:1,749,563...1,791,739
|
|
G |
Sf3b2 |
splicing factor 3b subunit 2 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:26619011 |
|
NCBI chrNW_004936599:3,477,882...3,494,366
Ensembl chrNW_004936599:3,477,589...3,494,354
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
protein:increased phosphorylation:peripheral blood mononuclear cell |
RGD |
PMID:29658610 |
RGD:21081544 |
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:253702 PMID:1565143 PMID:1565144 PMID:1631137 PMID:1683921 PMID:1978757 PMID:2046748 PMID:7478555 PMID:7651740 PMID:7732013 PMID:7737263 PMID:7791795 PMID:7887414 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8276238 PMID:8308926 PMID:8423216 PMID:8425176 PMID:8479749 PMID:8527048 PMID:8649776 PMID:8825920 PMID:9150393 PMID:9242456 PMID:9290701 PMID:9399838 PMID:9407971 PMID:9546439 PMID:9569050 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9704930 PMID:9825943 PMID:10064694 PMID:10089074 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10589545 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10922393 PMID:11051239 PMID:11139324 PMID:11180592 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11593407 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12406399 PMID:12506399 PMID:12672316 PMID:12700230 PMID:12826609 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15221755 PMID:15381368 PMID:15390294 PMID:15607980 PMID:15607981 PMID:15722483 PMID:15825182 PMID:15925506 PMID:15951970 PMID:16337994 PMID:16401470 PMID:16489069 PMID:16682957 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17308077 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17540308 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17881637 PMID:18307025 PMID:18511570 PMID:18685109 PMID:18937320 PMID:19101993 PMID:19147582 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19454241 PMID:19556618 PMID:19681600 PMID:19850740 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20505364 PMID:20516128 PMID:20522432 PMID:20593220 PMID:20693561 PMID:20805372 PMID:20878954 PMID:21056685 PMID:21059199 PMID:21113594 PMID:21115975 PMID:21118481 PMID:21159183 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21601526 PMID:21761402 PMID:22006311 PMID:22110706 PMID:22186996 PMID:22198284 PMID:22265402 PMID:22484423 PMID:22713868 PMID:22811390 PMID:22822097 PMID:22869713 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:22983585 PMID:23028800 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23263379 PMID:23484829 PMID:23538418 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24065105 PMID:24381225 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24744791 PMID:24810334 PMID:25157968 PMID:25256166 PMID:25293557 PMID:25294809 PMID:25339994 PMID:25404506 PMID:25503501 PMID:25504633 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25634208 PMID:25691460 PMID:25741868 PMID:25765855 PMID:25787918 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:26014290 PMID:26024390 PMID:26230955 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26681312 PMID:26781615 PMID:26787237 PMID:26822237 PMID:26845104 PMID:27050224 PMID:27179933 PMID:27276561 PMID:27328919 PMID:27374712 PMID:27463065 PMID:27493922 PMID:27501770 PMID:27523101 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27813088 PMID:27873457 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28152038 PMID:28160093 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28772286 PMID:28861920 PMID:28873162 PMID:29025599 PMID:29070607 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29752822 PMID:29979965 PMID:30076369 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30322717 PMID:30327374 PMID:30583724 PMID:30630526 PMID:30816478 PMID:31105275 PMID:31119730 PMID:31127191 PMID:31296311 PMID:31300551 PMID:31533767 PMID:31748977 PMID:31775759 PMID:31881331 PMID:31882575 PMID:32000721 PMID:32164171 PMID:32187361 PMID:32295079 PMID:32371905 PMID:32817165 PMID:32906206 PMID:33245408 PMID:33300245 PMID:33372952 PMID:33471991 PMID:33633026 PMID:33674644 PMID:33818021 PMID:34026625 PMID:34240179 PMID:34308366 PMID:34793666 PMID:34994652 PMID:35033608 PMID:35127508 PMID:35820297 PMID:36168441 PMID:36988593 More...
|
|
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Xpo1 |
exportin 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:26619011 |
|
NCBI chrNW_004936491:6,921,753...6,962,062
Ensembl chrNW_004936491:6,921,319...6,962,343
|
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21325069 |
|
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
|
|
G |
Alk |
ALK receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22474449 |
|
NCBI chrNW_004936493:3,624,288...3,671,567
Ensembl chrNW_004936493:3,028,608...3,671,874
|
|
G |
B2m |
beta-2-microglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7688627 |
|
NCBI chrNW_004936471:7,646,504...7,655,656
Ensembl chrNW_004936471:7,646,373...7,655,778
|
|
G |
Bcas2 |
BCAS2 pre-mRNA processing factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27356265 |
|
NCBI chrNW_004936690:2,900,003...2,913,427
Ensembl chrNW_004936690:2,900,002...2,913,381
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bcl6 |
BCL6 transcription repressor |
disease_progression |
ISO |
diffuse large B-cell lymphoma DNA:translocation:promoter,CDS:t(3;16)(q27;p11) results in IL21R promoter fused to BCL6 coding region |
RGD |
PMID:11821949 PMID:15701085 |
RGD:11530023 RGD:1600111 |
NCBI chrNW_004936578:2,371,976...2,395,034
Ensembl chrNW_004936578:2,371,945...2,395,071
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
|
|
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G |
Brca2 |
BRCA2 DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:9150172 PMID:18489799 PMID:20104584 PMID:21138478 PMID:22798144 PMID:22970155 PMID:24010542 PMID:24033266 PMID:24916970 PMID:25682074 PMID:25741868 PMID:25940717 PMID:26295337 PMID:26467025 PMID:26845104 PMID:28324225 PMID:28492532 PMID:28541631 PMID:28692638 PMID:28724667 PMID:28993434 PMID:29310832 PMID:29335925 PMID:29360550 PMID:29752822 PMID:29907814 PMID:30093976 PMID:30287823 PMID:30613976 PMID:30702160 PMID:30720243 PMID:30720863 PMID:30736435 PMID:30875412 PMID:31159747 PMID:31214711 PMID:31360904 PMID:31396961 PMID:31589614 PMID:31742824 PMID:31825140 PMID:31957001 PMID:32072338 PMID:32295079 PMID:32338768 PMID:32846166 PMID:32959997 PMID:33471991 PMID:33558524 PMID:36988593 More...
|
|
NCBI chrNW_004936472:26,945,659...27,017,693
|
|
G |
Btk |
Bruton tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:24869598 PMID:25082755 PMID:25189416 PMID:25741868 PMID:27199251 PMID:28049639 PMID:28212557 PMID:28418267 PMID:28492532 PMID:29496671 PMID:29875397 PMID:30018078 PMID:32455989 PMID:33154951 PMID:36029036 More...
|
|
NCBI chrNW_004936813:429,400...467,481
Ensembl chrNW_004936813:429,224...463,441
|
|
G |
Card11 |
caspase recruitment domain family member 11 |
|
ISO |
DNA:missense mutations:exons:multiple (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18323416 PMID:25049379 PMID:26192916 |
RGD:11100036 |
NCBI chrNW_004936823:580,438...621,298
Ensembl chrNW_004936823:581,955...621,208
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23828858 |
|
NCBI chrNW_004936581:2,072,607...2,078,668
Ensembl chrNW_004936581:2,072,886...2,078,605
|
|
G |
Cd22 |
CD22 molecule |
treatment |
ISO |
|
RGD |
PMID:25708834 |
RGD:151665133 |
NCBI chrNW_004936570:960,592...971,688
Ensembl chrNW_004936570:960,746...969,049
|
|
G |
Cd40 |
CD40 molecule |
susceptibility |
ISO |
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) |
RGD |
PMID:20473910 |
RGD:5490541 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd79a |
CD79a molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25049379 |
|
NCBI chrNW_004936706:561,195...564,577
Ensembl chrNW_004936706:561,140...564,661
|
|
G |
Cd79b |
CD79b molecule |
treatment severity |
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma DNA:missense mutation:multiple, exon 5 (human) |
RGD ClinVar |
PMID:11160144 PMID:25708834 PMID:31402495 PMID:31609782 |
RGD:151665133 RGD:151665203 |
NCBI chrNW_004936541:4,534,233...4,537,448
Ensembl chrNW_004936541:4,534,246...4,537,590
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19223503 |
|
NCBI chrNW_004936614:2,300,682...2,313,611
Ensembl chrNW_004936614:2,300,513...2,313,624
|
|
G |
Chek2 |
checkpoint kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:16199547 PMID:21876083 PMID:24713400 PMID:28492532 |
|
NCBI chrNW_004936657:2,805,947...2,848,180
Ensembl chrNW_004936657:2,805,959...2,848,180
|
|
G |
Cltc |
clathrin heavy chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22474449 |
|
NCBI chrNW_004936490:3,659,682...3,726,222
Ensembl chrNW_004936490:3,657,242...3,726,274
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:24755471 PMID:28481359 PMID:30239046 PMID:33323405 |
|
NCBI chrNW_004936694:552,447...663,237
Ensembl chrNW_004936694:553,753...663,617
|
|
G |
Dicer1 |
dicer 1, ribonuclease III |
disease_progression |
ISO |
|
RGD |
PMID:25195038 |
RGD:149735347 |
NCBI chrNW_004936846:528,768...584,599
Ensembl chrNW_004936846:532,972...575,689
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:25363760 PMID:25741868 PMID:29900417 PMID:30478443 PMID:32581362 PMID:33238114 PMID:34315901 More...
|
|
NCBI chrNW_004936493:6,963,406...7,013,256
Ensembl chrNW_004936493:6,935,386...7,007,610
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:35053500 |
|
NCBI chrNW_004936587:5,328,467...5,457,260
Ensembl chrNW_004936587:5,330,665...5,457,264
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20081860 PMID:28438623 |
RGD:126779596 |
NCBI chrNW_004936527:5,024,077...5,069,152
Ensembl chrNW_004936527:5,024,068...5,063,939
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26192916 |
|
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fcgr2a |
Fc fragment of IgG receptor IIa |
disease_progression |
ISO |
DNA:SNP: :rs1801274 (human) |
RGD |
PMID:27282998 |
RGD:11344967 |
NCBI chrNW_004937131:15,542...22,099
|
|
G |
Foxo1 |
forkhead box O1 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:26314988 PMID:29721381 PMID:35079069 |
|
NCBI chrNW_004936565:5,210,014...5,299,213
Ensembl chrNW_004936565:5,210,014...5,302,436
|
|
G |
Gli1 |
GLI family zinc finger 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625222 |
|
NCBI chrNW_004936646:1,622,308...1,629,787
Ensembl chrNW_004936646:1,622,308...1,629,779
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
DNA:SNP: :(rs1695)(human) |
RGD |
PMID:19338043 |
RGD:8547939 |
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
disease_progression |
ISO |
proteion:increased expression:serum: |
RGD |
PMID:12598355 |
RGD:11354982 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
diffuse large B-cell lymphoma DNA:translocation:promoter,CDS:t(3;16)(q27;p11) results in IL21R promoter fused to BCL6 coding region |
RGD |
PMID:11821949 |
RGD:1600111 |
NCBI chrNW_004936501:11,100,170...11,112,112
Ensembl chrNW_004936501:11,100,170...11,110,744
|
|
G |
Immp2l |
inner mitochondrial membrane peptidase subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27356265 |
|
|
|
G |
Irf4 |
interferon regulatory factor 4 |
disease_progression |
ISO |
|
RGD |
PMID:15701085 |
RGD:11530023 |
NCBI chrNW_004936633:1,565,293...1,580,859
Ensembl chrNW_004936633:1,564,637...1,580,859
|
|
G |
Kmt2d |
lysine methyltransferase 2D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21804550 |
|
NCBI chrNW_004936512:6,819,240...6,860,852
Ensembl chrNW_004936512:6,822,057...6,854,451
|
|
G |
Malt1 |
MALT1 paracaspase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chrNW_004936497:5,854,361...5,910,719
Ensembl chrNW_004936497:5,853,870...5,904,266
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:20919850 |
RGD:6483541 |
NCBI chrNW_004936486:15,561,327...15,587,109
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:transition, transversion, haplotype:cds:g.677C>T, g.1298A>C (human) |
RGD |
PMID:17712558 |
RGD:6893517 |
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27356265 |
|
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
severity |
ISO |
DNA:missense mutation:L265P (human) ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
RGD ClinVar |
PMID:21179087 PMID:22931316 PMID:23215570 PMID:23355535 PMID:26619011 PMID:28492532 PMID:31609782 More...
|
RGD:151665203 |
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
G |
Nbn |
nibrin |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:9590180 PMID:16415040 PMID:28492532 |
|
NCBI chrNW_004936544:3,773,828...3,812,673
Ensembl chrNW_004936544:3,775,220...3,808,837
|
|
G |
Nectin2 |
nectin cell adhesion molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27356265 |
|
NCBI chrNW_004936706:1,470,910...1,498,986
Ensembl chrNW_004936706:1,470,738...1,498,993
|
|
G |
Nf1 |
neurofibromin 1 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:21390130 PMID:22158541 PMID:23292937 |
|
NCBI chrNW_004936538:3,394,623...3,596,025
Ensembl chrNW_004936538:3,398,222...3,595,261
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
no_association |
ISO |
SNA:polymorphism(s) |
RGD |
PMID:15198731 |
RGD:2298905 |
NCBI chrNW_004936494:9,537,793...9,541,187
Ensembl chrNW_004936494:9,537,008...9,541,612
|
|
G |
Nom1 |
nucleolar protein with MIF4G domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22474449 |
|
NCBI chrNW_004936797:644,431...661,606
Ensembl chrNW_004936797:642,693...658,102
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chrNW_004936694:1,444,819...1,487,628
Ensembl chrNW_004936694:1,444,880...1,488,265 Ensembl chrNW_004936694:1,444,880...1,488,265
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chrNW_004936566:3,924,013...3,951,052
Ensembl chrNW_004936566:3,923,934...3,951,073
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chrNW_004936540:907,118...1,041,814
Ensembl chrNW_004936540:907,112...1,041,848
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chrNW_004936623:3,672,201...3,696,959
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chrNW_004936479:17,084,006...17,112,264
Ensembl chrNW_004936479:17,084,920...17,112,258
|
|
G |
Pms2 |
PMS1 homolog 2, mismatch repair system component |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
|
|
NCBI chrNW_004936750:439,396...468,747
|
|
G |
Prdm1 |
PR/SET domain 1 |
disease_progression |
ISO |
|
RGD |
PMID:22321048 |
RGD:150530470 |
NCBI chrNW_004936564:2,594,362...2,690,680
Ensembl chrNW_004936564:2,667,660...2,690,683
|
|
G |
Prdx3 |
peroxiredoxin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chrNW_004936486:8,597,479...8,606,727
Ensembl chrNW_004936486:8,597,388...8,606,780
|
|
G |
Prdx4 |
peroxiredoxin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chrNW_004936624:859,281...873,784
Ensembl chrNW_004936624:859,276...873,860
|
|
G |
Prmt5 |
protein arginine methyltransferase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31123343 |
|
NCBI chrNW_004936722:1,379,515...1,388,538
Ensembl chrNW_004936722:1,379,515...1,388,546
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:10468583 PMID:10555148 PMID:10698513 PMID:10866302 PMID:10866658 PMID:11035045 PMID:11504908 PMID:12297295 PMID:15016963 PMID:15254419 PMID:15647370 PMID:17526800 PMID:17526801 PMID:18725974 PMID:18986487 PMID:19265751 PMID:19366826 PMID:19903786 PMID:20085938 PMID:20453058 PMID:20533527 PMID:20619739 PMID:21194675 PMID:22162582 PMID:22162589 PMID:22628360 PMID:23335809 PMID:24778394 PMID:24905788 PMID:25157968 PMID:25336918 PMID:25448482 PMID:25669429 PMID:25741868 PMID:28475857 PMID:28492532 PMID:28526761 PMID:29874181 More...
|
|
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Rangap1 |
Ran GTPase activating protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27150054 |
|
NCBI chrNW_004936492:595,905...626,219
Ensembl chrNW_004936492:595,938...626,213
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19223503 |
|
NCBI chrNW_004936490:3,441,046...3,492,917
Ensembl chrNW_004936490:3,441,055...3,492,917
|
|
G |
Sec31a |
SEC31 homolog A, COPII coat complex component |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22474449 |
|
NCBI chrNW_004936738:1,664,916...1,741,739
Ensembl chrNW_004936738:1,676,436...1,744,896
|
|
G |
Sf3a1 |
splicing factor 3a subunit 1 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:22037554 PMID:26498691 PMID:33563892 |
|
NCBI chrNW_004936904:310,182...328,882
Ensembl chrNW_004936904:309,713...332,684
|
|
G |
Skp2 |
S-phase kinase associated protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18850583 |
|
NCBI chrNW_004936518:5,635,856...5,664,057
Ensembl chrNW_004936518:5,637,331...5,664,778
|
|
G |
Smurf2 |
SMAD specific E3 ubiquitin protein ligase 2 |
|
ISO |
|
MouseDO |
|
|
NCBI chrNW_004936541:5,046,147...5,147,416
Ensembl chrNW_004936541:5,046,148...5,106,008
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:19734449 PMID:23296022 PMID:26336985 PMID:28302137 PMID:29625055 |
|
NCBI chrNW_004936530:9,312,965...9,315,593
Ensembl chrNW_004936530:9,312,965...9,316,165
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:21690253 PMID:22591296 PMID:22859607 PMID:23926297 PMID:25873174 PMID:26702067 PMID:28492532 PMID:29162862 PMID:29180260 PMID:30940614 PMID:31737384 PMID:31770611 PMID:31771617 PMID:32231398 PMID:36240433 More...
|
|
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Syk |
spleen associated tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33782605 |
|
NCBI chrNW_004936780:1,553,605...1,601,036
Ensembl chrNW_004936780:1,553,605...1,598,158
|
|
G |
Tbl1xr1 |
TBL1X/Y related 1 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:9450851 PMID:16492805 PMID:21156281 PMID:21156282 PMID:25741868 PMID:26769062 PMID:28492532 PMID:28562391 PMID:32619424 PMID:32932517 PMID:35165208 More...
|
|
NCBI chrNW_004936566:5,721,541...5,861,838
Ensembl chrNW_004936566:5,790,532...5,861,838
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:1631137 PMID:1978757 PMID:8062826 PMID:8099841 PMID:8425176 PMID:8527048 PMID:9150393 PMID:9242456 PMID:9598730 PMID:9825943 PMID:10089074 PMID:10414702 PMID:11051239 PMID:11782540 PMID:12826609 PMID:14743206 PMID:16489069 PMID:16818505 PMID:17417627 PMID:17427234 PMID:17606709 PMID:17881637 PMID:19378321 PMID:20013323 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20522432 PMID:21059199 PMID:21343334 PMID:21519010 PMID:21601526 PMID:22186996 PMID:22265402 PMID:22713868 PMID:22915647 PMID:22955915 PMID:23172776 PMID:23246812 PMID:23667202 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24573247 PMID:24603336 PMID:24651015 PMID:25157968 PMID:25741868 PMID:25925845 PMID:25952993 PMID:26230955 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26787237 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28369373 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28985567 PMID:29025599 PMID:29979965 PMID:30224644 PMID:30327374 PMID:31127191 PMID:31775759 PMID:32187361 PMID:36988593 More...
|
|
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Txnip |
thioredoxin interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chrNW_004936867:722,544...726,595
Ensembl chrNW_004936867:722,514...726,617
|
|
|
G |
LOC101954516 |
signal transducer and activator of transcription 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29200404 |
|
NCBI chrNW_004936490:17,022,268...17,043,751
Ensembl chrNW_004936490:17,021,051...17,043,941
|
|
G |
Setd2 |
SET domain containing 2, histone lysine methyltransferase |
|
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:27600764 |
RGD:150429643 |
NCBI chrNW_004936596:795,940...898,823
Ensembl chrNW_004936596:796,601...883,373
|
|
|
G |
Bcl10 |
BCL10 immune signaling adaptor |
|
ISO |
ClinVar Annotator: match by term: MALT lymphoma |
OMIM ClinVar |
PMID:9989495 PMID:10380920 PMID:10408400 |
|
NCBI chrNW_004936608:434,740...442,162
Ensembl chrNW_004936608:434,978...442,391
|
|
G |
Birc3 |
baculoviral IAP repeat containing 3 |
treatment |
ISO |
DNA:gene fusion: (human) |
RGD |
PMID:21465313 |
RGD:153305955 |
NCBI chrNW_004936551:5,544,047...5,556,550
Ensembl chrNW_004936551:5,544,065...5,556,555
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
protein:increased expression: mucosa-associated lymphoid tissue (human) |
RGD |
PMID:27544389 |
RGD:152023632 |
NCBI chrNW_004936469:39,794,613...39,798,448
Ensembl chrNW_004936469:39,794,584...39,798,459
|
|
|
G |
Atp6ap1 |
ATPase H+ transporting accessory protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26691987 |
|
NCBI chrNW_004936809:1,179,507...1,188,172
Ensembl chrNW_004936809:1,179,464...1,188,283
|
|
G |
Atp6v1b2 |
ATPase H+ transporting V1 subunit B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26691987 |
|
NCBI chrNW_004936555:4,285,269...4,307,715
Ensembl chrNW_004936555:4,285,269...4,310,858
|
|
G |
Bcl10 |
BCL10 immune signaling adaptor |
|
ISO |
ClinVar Annotator: match by term: Follicular lymphoma |
ClinVar |
PMID:9989495 |
|
NCBI chrNW_004936608:434,740...442,162
Ensembl chrNW_004936608:434,978...442,391
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
susceptibility |
ISO |
DNA:translocation: ;t(14;18)(q32;q21) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:3287162 PMID:12855623 PMID:16671111 |
RGD:1599473 RGD:734639 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Cd40 |
CD40 molecule |
susceptibility |
ISO |
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) |
RGD |
PMID:20473910 |
RGD:5490541 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
human gene in a mouse model |
RGD |
PMID:25582824 |
RGD:11344981 |
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G |
Cd79b |
CD79b molecule |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:17374736 |
RGD:151665154 |
NCBI chrNW_004936541:4,534,233...4,537,448
Ensembl chrNW_004936541:4,534,246...4,537,590
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chrNW_004936694:552,447...663,237
Ensembl chrNW_004936694:553,753...663,617
|
|
G |
Ebf1 |
EBF transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chrNW_004936515:4,266,419...4,643,702
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chrNW_004936527:5,024,077...5,069,152
Ensembl chrNW_004936527:5,024,068...5,063,939
|
|
G |
Irf4 |
interferon regulatory factor 4 |
severity |
ISO |
|
RGD |
PMID:17296585 |
RGD:11530032 |
NCBI chrNW_004936633:1,565,293...1,580,859
Ensembl chrNW_004936633:1,564,637...1,580,859
|
|
G |
Kdsr |
3-ketodihydrosphingosine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:8417785 PMID:25526675 |
RGD:1598985 |
NCBI chrNW_004936497:2,169,982...2,199,600
Ensembl chrNW_004936497:2,169,712...2,203,150
|
|
G |
Kmt2d |
lysine methyltransferase 2D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chrNW_004936512:6,819,240...6,860,852
Ensembl chrNW_004936512:6,822,057...6,854,451
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16410450 |
|
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16410450 |
|
NCBI chrNW_004936484:16,087,924...16,180,089
Ensembl chrNW_004936484:16,087,923...16,180,148
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
G |
Rarres1 |
retinoic acid receptor responder 1 |
|
ISO |
OMIM:151430 |
MouseDO |
|
|
NCBI chrNW_004936519:5,296,508...5,329,214
Ensembl chrNW_004936519:5,296,491...5,329,557
|
|
G |
Rragc |
Ras related GTP binding C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26691987 |
|
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chrNW_004936560:5,124,955...5,138,988
Ensembl chrNW_004936560:5,128,843...5,138,345
|
|
G |
Tyms |
thymidylate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16410450 |
|
NCBI chrNW_004936550:33,797...42,233
Ensembl chrNW_004936550:34,048...41,840
|
|
|
G |
Kmt2d |
lysine methyltransferase 2D |
disease_progression |
ISO |
|
RGD |
PMID:26722499 |
RGD:11553660 |
NCBI chrNW_004936512:6,819,240...6,860,852
Ensembl chrNW_004936512:6,822,057...6,854,451
|
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
|
RGD |
PMID:8843970 |
RGD:11353776 |
NCBI chrNW_004936529:997,943...999,123
Ensembl chrNW_004936529:998,150...998,987
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
|
RGD |
PMID:9613675 |
RGD:11522762 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241536 |
|
NCBI chrNW_004936471:26,589,251...26,628,302
Ensembl chrNW_004936471:26,589,161...26,628,302
|
|
G |
Tnfsf8 |
TNF superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chrNW_004936487:4,057,637...4,081,207
Ensembl chrNW_004936487:4,057,643...4,081,207
|
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7621881 |
|
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7621881 PMID:8656679 |
|
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G |
Cd68 |
CD68 molecule |
severity |
ISO |
protein:increased expression:tumor (human) associated with Epstein-Barr Virus Infections;protein:increased expression:tumor(human) |
RGD |
PMID:21071500 PMID:23045593 |
RGD:40925944 RGD:40925946 |
NCBI chrNW_004936595:858,289...861,131
|
|
G |
Cflar |
CASP8 and FADD like apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17659339 |
|
NCBI chrNW_004936726:381,888...425,565
Ensembl chrNW_004936726:381,835...423,311
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17562247 |
|
NCBI chrNW_004936490:15,142,526...15,146,375
Ensembl chrNW_004936490:15,142,808...15,144,487
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Classic Hodgkin lymphoma |
ClinVar |
PMID:28492532 PMID:32934698 |
|
NCBI chrNW_004936477:21,591,772...21,606,289
Ensembl chrNW_004936477:21,591,792...21,606,296
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
ISO |
ClinVar Annotator: match by term: Classic Hodgkin lymphoma |
ClinVar |
PMID:25741868 PMID:32934698 |
|
NCBI chrNW_004936597:1,388,394...1,397,731
Ensembl chrNW_004936597:1,385,624...1,397,758
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21037568 |
|
NCBI chrNW_004936484:6,780,692...6,800,883
Ensembl chrNW_004936484:6,780,692...6,800,966
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11406608 |
|
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
|